75000 - Document - Cover Page
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - Statements of Consolidated Financial Position
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - Statements of Consolidated Operations
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - Statements of Consolidated Operations 2
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Statements of Consolidated Comprehensive Income (Loss)
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - Statements of Consolidated Comprehensive Income (Loss) 2
link:presentationLink
link:calculationLink
link:definitionLink
75060 - Statement - Statements of Consolidated Cash Flows
link:presentationLink
link:calculationLink
link:definitionLink
75070 - Statement - Statements of Consolidated Cash Flows 2
link:presentationLink
link:calculationLink
link:definitionLink
75080 - Statement - Statements of Consolidated Cash Flows (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75090 - Statement - Condensed Statements of Changes in Consolidated Shareholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
995457 - Disclosure - Cybersecurity Risk Management, Strategy and Governance
link:presentationLink
link:calculationLink
link:definitionLink
995467 - Disclosure - The Company
link:presentationLink
link:calculationLink
link:definitionLink
995477 - Disclosure - Accounting principles
link:presentationLink
link:calculationLink
link:definitionLink
995487 - Disclosure - Scope of consolidation and non-consolidated entities
link:presentationLink
link:calculationLink
link:definitionLink
995497 - Disclosure - Information concerning the Group's Consolidated Operations
link:presentationLink
link:calculationLink
link:definitionLink
995507 - Disclosure - Discontinued operations
link:presentationLink
link:calculationLink
link:definitionLink
995517 - Disclosure - Impairment tests
link:presentationLink
link:calculationLink
link:definitionLink
995527 - Disclosure - Intangible assets
link:presentationLink
link:calculationLink
link:definitionLink
995537 - Disclosure - Right-of-use assets
link:presentationLink
link:calculationLink
link:definitionLink
995547 - Disclosure - Property, plant and equipment
link:presentationLink
link:calculationLink
link:definitionLink
995557 - Disclosure - Financial assets and liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995567 - Disclosure - Non-current financial assets and Other non-current assets
link:presentationLink
link:calculationLink
link:definitionLink
995577 - Disclosure - Trade receivables and other current assets
link:presentationLink
link:calculationLink
link:definitionLink
995587 - Disclosure - Current financial assets and Cash and cash equivalents
link:presentationLink
link:calculationLink
link:definitionLink
995597 - Disclosure - Financial liabilities and lease debts
link:presentationLink
link:calculationLink
link:definitionLink
995607 - Disclosure - Other current liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995617 - Disclosure - Deferred income and contract liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995627 - Disclosure - Capital
link:presentationLink
link:calculationLink
link:definitionLink
995637 - Disclosure - Share-based payments
link:presentationLink
link:calculationLink
link:definitionLink
995647 - Disclosure - Earnings per share
link:presentationLink
link:calculationLink
link:definitionLink
995657 - Disclosure - Provisions
link:presentationLink
link:calculationLink
link:definitionLink
995667 - Disclosure - Off-balance sheet commitments
link:presentationLink
link:calculationLink
link:definitionLink
995677 - Disclosure - Related parties and other major shareholders
link:presentationLink
link:calculationLink
link:definitionLink
995687 - Disclosure - Subsequent events
link:presentationLink
link:calculationLink
link:definitionLink
995697 - Disclosure - Accounting principles (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995707 - Disclosure - Accounting Principles (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995717 - Disclosure - Scope of consolidation and non-consolidated entities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995727 - Disclosure - Information concerning the Group's Consolidated Operations (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995737 - Disclosure - Discontinued operations (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995747 - Disclosure - Intangible assets (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995757 - Disclosure - Right-of-use assets (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995767 - Disclosure - Property, plant and equipment (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995777 - Disclosure - Trade receivables and other current assets (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995787 - Disclosure - Financial assets and liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995797 - Disclosure - Current financial assets and Cash and cash equivalents (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995807 - Disclosure - Financial liabilities and lease debts (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995817 - Disclosure - Other current liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995827 - Disclosure - Deferred Income and contract liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995837 - Disclosure - Capital (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995847 - Disclosure - Share-based payments (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995857 - Disclosure - Earnings per share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995867 - Disclosure - Provisions (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995877 - Disclosure - Off-balance sheet commitments (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995887 - Disclosure - Related parties and other major shareholders (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995897 - Disclosure - The Company - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995907 - Disclosure - Accounting Principles - Fair value of Initial Investment Agreement at Initial Recognition Date Determined on Basis of Share Price (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995917 - Disclosure - Accounting Principles - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995927 - Disclosure - Accounting Principles - Summary of Assumptions Used and Estimated Fair Value (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995937 - Disclosure - Accounting Principles - Schedule of Sensitivity of Derivative Fair Value to Probability of Transaction Completion (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995947 - Disclosure - Accounting Principles - Schedule of Sensitivity of Derivative Fair Value to Probability of Transaction Completion (Parenthetical) (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995957 - Disclosure - Accounting Principles - Schedule of Sensitivity of Derivative Fair Value to Expected Life of Derivative (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995967 - Disclosure - Accounting Principles - Schedule of Sensitivity of Derivative Fair Value to Expected life (Parenthetical) (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995977 - Disclosure - Scope of Consolidation and Non-Consolidated Entities - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995987 - Disclosure - Scope of consolidation and non-consolidated entities - Impact of Deconsolidation on Group's Financial Statements (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995997 - Disclosure - Information Concerning the Group's Consolidated Operations - Revenues by Country of Origin and Other Income (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996007 - Disclosure - Information Concerning the Group's Consolidated Operations - Revenues by Nature (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996017 - Disclosure - Information Concerning the Group's Consolidated Operations - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996027 - Disclosure - Information Concerning the Group's Consolidated Operations - Details of Operating Expenses by Nature (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996037 - Disclosure - Information Concerning the Group's Consolidated Operations - Details of Financial Income and Expenses (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996047 - Disclosure - Information Concerning the Group's Consolidated Operations - Disclosure of Income Tax (Expense or Income) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996057 - Disclosure - Information concerning the Group's Consolidated Operations - Disclosure of Income Tax (Expense or Income) (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996067 - Disclosure - Information concerning the Group's Consolidated Operations - Disclosure of Deferred Tax Assets and Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996077 - Disclosure - Information concerning the Group's Consolidated Operations - Disclosure of Deferred Tax Assets and Liabilities (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
996087 - Disclosure - Information concerning the Group's Consolidated Operations - Disclosure of Deferred Tax Assets and Liabilities Reflected in the Statement of financial Position (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996097 - Disclosure - Discontinued Operations - Schedule Of Income Statement Of Discontinued Operations (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996107 - Disclosure - Discontinued Operations - Schedule Of Cash Flow Statement Of Discontinued Operations (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996117 - Disclosure - Impairment Tests - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996127 - Disclosure - Intangible Assets - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996137 - Disclosure - Intangible Assets - Details Information About Intangible Assets (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996147 - Disclosure - Right-of-use Assets - Details Information About Breakdown Of Right Of Use Assets (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996157 - Disclosure - Right-of-use assets - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996167 - Disclosure - Property, plant and equipment - Summary of Property, Plant and Equipment Estimated Useful Lives (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996177 - Disclosure - Property, Plant and Equipment - Disclosure of Property, Plant and Equipment (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996187 - Disclosure - Property, plant and equipment - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996197 - Disclosure - Financial assets and liabilities (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996207 - Disclosure - Financial Assets and Liabilities - Summary of Financial Assets and Liabilities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996217 - Disclosure - Financial assets and liabilities - Summary of Cash, Cash Equivalents and Current Financial Assets Denominated in US Dollars Affected Profit or Loss and Equity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996227 - Disclosure - Financial assets and liabilities - Summary of cash and cash equivalents and current financial assets denominated in us dollars affected equity and profit or loss (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996237 - Disclosure - Non-current Financial Assets and Other Non-current Assets - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996247 - Disclosure - Current Financial Assets and Cash and Cash Equivalents - Summary of Current Financial Assets and Cash and Cash Equivalents (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996257 - Disclosure - Trade Receivables and Other Current Assets - Disclosure of Trade Receivables (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996267 - Disclosure - Trade Receivables and Other Current Assets - Disclosure of Subsidies Receivables (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996277 - Disclosure - Trade Receivables and Other Current Assets - Disclosure of Subsidies Receivables (Detail) 2
link:presentationLink
link:calculationLink
link:definitionLink
996287 - Disclosure - Trade Receivables and Other Current Assets - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996297 - Disclosure - Trade Receivables and Other Current Assets - Disclosure of Other Current Assets (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996307 - Disclosure - Current Financial Assets and Cash and Cash Equivalents - Summary of Cash and Cash Equivalents (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996317 - Disclosure - Current Financial Assets and Cash and Cash Equivalents - Summary of Cash and Cash Equivalents (Detail) 2
link:presentationLink
link:calculationLink
link:definitionLink
996327 - Disclosure - Current Financial Assets and Cash and Cash Equivalents - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996337 - Disclosure - Financial Liabilities and Lease Debts - Schedule of Financial Liabilities and Lease Debts (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996347 - Disclosure - Financial Liabilities and Lease Debts - Schedule of reconciliation of movements of liabilities to cash flows arising from financing liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996357 - Disclosure - Financial Liabilities and Lease Debts - Schedule of reconciliation of movements of liabilities to cash flows arising from financing liabilities (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996367 - Disclosure - Financial Liabilities and Lease Debts - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996377 - Disclosure - Financial Liabilities and Lease Debts - Summary of Assumptions and Results of the Warrant Valuation (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996387 - Disclosure - Financial Liabilities and Lease Debts - Disclosure of Sensitivity on the Expected Volatility (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996397 - Disclosure - Financial Liabilities and Lease Debts - Schedule Representing Remaining Contractual Maturities of Financial Liabilities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996407 - Disclosure - Financial assets and liabilities - Schedule Of Derivative Instruments Combination Of Put And Call Options (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996417 - Disclosure - Other Current Liabilities - Summary of Other Current Liabilities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996427 - Disclosure - Other Current Liabilities - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996437 - Disclosure - Deferred Income and Contract Liabilities - Summary of Deferred income and Contract Liabilities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996447 - Disclosure - Deferred Income and Contract Liabilities - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996457 - Disclosure - Capital - Schedule of Share Capital Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996467 - Disclosure - Capital - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996477 - Disclosure - Capital - Disclosure of Share Warrants and Non-employee Warrants (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996487 - Disclosure - Share-based payments - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996497 - Disclosure - Share-based Payments - Summary of assumptions Vesting Details (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996507 - Disclosure - Share-Based Payments - Summary of Information on Stock Option Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996517 - Disclosure - Share-Based Payments - Summary of assumptions Weighted-average Fair Values of Warrants Granted and Assumptions Used for Black-Scholes Option Pricing Model (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996527 - Disclosure - Share-Based Payments - Summary of Information on Warrants Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996537 - Disclosure - Share-Based Payments - Summary of Number of Shares Outstanding and Weighted Average Grant Date Fair Value (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996547 - Disclosure - Earnings Per Share - Details of Earnings Per Share (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996557 - Disclosure - Provisions - Summary of Provisions (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996567 - Disclosure - Provisions - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996577 - Disclosure - Provisions - Schedule of Estimation of Retirement Indemnity to Employee (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996587 - Disclosure - Provisions - Summary of Net Defined Benefit Liability and Components (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996597 - Disclosure - Off-balance Sheet Commitments - Schedule of Off-balance Sheet Commitments (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996607 - Disclosure - Off-Balance Sheet Commitments - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996617 - Disclosure - Related parties and other major shareholders - Schedule of Outstanding Balances with Related Parties (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996627 - Disclosure - Related parties and other major shareholders - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996637 - Disclosure - Subsequent events - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
999009 - Disclosure - Anchoring
link:presentationLink
link:calculationLink
link:definitionLink
Carryforwards That Can Be Offset Against Future Taxable Profit, Percentage Profit Exceeding Limit
Carryforwards That Can Be Offset Against Future Taxable Profit, Percentage Profit Exceeding Limit
Carryforwards limit that can be offset against future taxable profit, additional percentage of profit exceeding the limit
Disclosure of financial assets [table]
Financial liabilities at amortised cost
Accounting category amortized cost
Financial liabilities at amortised cost
Current prepaid expenses
Prepaid expenses and other prepayments
Schedule of outstanding balances with related parties explanatory.
Schedule of outstanding balances with related parties explanatory [Table Text Block]
Schedule of outstanding balances with related parties
Sales of non-current financial assets, classified as investing activities.
Sales of Non-Current Financial Assets, Classified as Investing Activities
Sales of non-current financial assets
Sales of non-current financial assets
Reserve of exchange differences on translation
Currency translation adjustment
Cash repayments of advances and loans from related parties
Loan principal payment
Land and buildings [member]
Land and Buildings [Member]
Gain in fair value of SIA derivative instrument.
Gain in Fair Value of SIA Derivative Instrument
Gain in Fair Value of SIA Derivative Instrument
Gain in fair value of SIA derivative instrument
Astra Zeneca Ireland [Member]
Astra Zeneca Ireland [Member]
Reclassification adjustments on intangible assets.
Reclassification Adjustments On Intangible Assets
Reclassification
Research and development expenses.
Research and development expenses [member]
Research and Development Expenses [Member]
Top of range [member]
Top of Range [member]
Interest expense
Increase (decrease) through effect of changes in foreign exchange rates, liabilities arising from financing activities
Currency translation adjustment financial liabilities and lease debts
Other current assets.
Other Current Assets [abstract]
Entity Incorporation, State or Country Code
October twenty eight two thousand sixteen.
October twenty eight two thousand sixteen [member]
10/28/2016 [member]
November Eight Thous and Twenty Two
November Eight Thous and Twenty Two [Member]
11/08/2022 [member]
March Twenty NineThousandTwenty Two
03/29/2022 [member]
Actuarial assumption of discount rates
Discount rate
Expected dividends warrants.
Expected Dividends Warrants
Expected dividends
Warrants valuation method.
Warrants Valuation Method
Valuation method
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, assets [text block]
Schedule of Sensitivity of Derivative Fair Value to Probability of Transaction Completion
Entity Current Reporting Status
Number Of Options Or Warrants Exercised In Share Based Payment Arrangement
Number of options or warrants exercised in share based payment arrangement.
Number of options/warrants exercised
Cash from continuing operations
Cash and cash equivalents from continuing operations
Cash and cash equivalents from continuing operations.
Increase (decrease) through share-based payment transactions, equity
Non-cash stock-based compensation expense
November Twenty Fifth Two Thousand And Twenty One [Member]
November twenty fifth two thousand and twenty one.
11/25/2021 [member]
Effects Of Profit And Loss And Equity Net Of Tax [Axis]
Effects of profit and loss and equity net of tax.
Classes of property, plant and equipment [axis]
Classes of property, plant and equipment [axis]
Income tax receivable current.
Income Tax Receivable Current
Income tax receivable
Payments of lease liabilities, classified as financing activities
Payments on lease debts
Payments of lease liabilities
Percentage of decrease in salary increase rate.
Percentage Of Decrease In Salary Increase Rate
Percentage of decrease in salary increase rate
Gains (losses) recognised in profit or loss including exchange differences, fair value measurement, assets
Total gains (losses) recognised in profit or loss including exchange differences, fair value measurement, assets
Loss in fair value recognized in profit and loss
Increase decrease in other income.
Increase Decrease In Other Income
Decrease in other income
Number Of Exercisable Share Options Forfeited In Share Based Payment Arrangement
Number of exercisable share options forfeited in share based payment arrangement.
Option exercisable, forfeited or expired
Non-current lease liabilities
Non-current lease debts
Lease debts
Financial Institution [Domain]
Initial investment agreement.
Initial Investment Agreement [Member]
Initial Investment Agreement
Agreement one.
Agreement One [Axis]
Classes of financial assets [axis]
Document Fiscal Period Focus
Document Fiscal Period Focus
Description of voting right.
Description of voting right
Voting right description
Percentage Of Shareholding Diluted Of Merged Entity
Percentage Of Shareholding Diluted Of Merged Entity
Percentage Of Shareholding Diluted Of Merged Entity
Percentage of shareholding diluted of merged entity
Disclosure of detailed information about intangible assets [abstract]
Entity Shell Company
Derivatives by name.
Derivatives By Name [Domain]
Cash flows from (used in) investing activities, continuing operations
Net cash flows from (used in) investing activities, continuing operations
Net cash flows provided by (used in) investing activities of continuing operations
Vesting Period, Share-based Payment Arrangements
Vesting period, share-based payment arrangements.
Vesting period, years
Increase In Foreign Exchange Gains
Increase in foreign exchange gains.
Increase in foreign exchange gains
Purchase of other long-term assets, classified as investing activities
Acquisition of non-current financial assets
Purchase of other long-term assets
Spot foreign exchange rate
Spot foreign exchange rate.
Grant And Refundable Advance Agreement
Grant And Refundable Advance Agreement [Member]
Grant and refundable advance agreement [Member]
Grant and Refundable Advance Agreement [Member]
This table concepts are used to disclose the amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity.
Expense By Nature [Table]
Expense By Nature [Table]
Cash flows from (used in) financing activities
Net cash flows provided by (used in) financing activities
Net cash flows from (used in) financing activities
Cybersecurity Risk Management, Strategy, and Governance [Abstract]
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]
Cybersecurity Risk Board of Directors Oversight [Text Block]
Non current provisions used during the period.
Non Current Provisions Used During the Period
Non current provisions Amounts used during period
Contractual commitments.
Contractual commitments
Total commitments
Class A common stock.
Class A Common Stock [Member]
Class A Common Stock [Member]
Issue of equity
Capital increase of Cellectis
Capital increase
Other current financial assets
Other current financial assets (deposits)
Joint collaboration and research agreement.
Joint collaboration and research agreement [member]
Joint Collaboration and Research Agreement [Member]
Extended period
Borrowing extended period
Borrowing extended period.
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Call Options May Fifteenth And Twenty Twenty Six [Member]
Call options may fifteenth and twenty twenty six.
Call options
Agreement
Agreement [Domain]
Classes of commitments.
Classes of commitments [domain]
Finance costs
Financial expenses
Total Financial expenses
Net cash flows provided by (used in) financing activities of continuing operations
Cash flows from (used in) financing activities, continuing operations
Net cash flows from (used in) financing activities, continuing operations
Derivative Instruments Fair Value
Derivative instruments fair value.
Impact Of Deconsolidation Of Financial Statements [Table Text Block]
Impact of deconsolidation of financial statements.
Impact of Deconsolidation on Group's Financial Statements
Capital Evolution 2025.
Capital Evolution 2025 [Member]
Accruals and deferred income including contract liabilities.
Accruals and deferred income including contract liabilities [Table]
Entity Filer Category
Basic net income (loss) attributable to shareholders of Cellectis per share ($ /share) from discontinued operations
Basic net income (loss) attributable to shareholders of Cellectis from discontinued operations, per share ($ /share)
Basic net income (loss) attributable to shareholders of Cellectis from discontinued operations, per share ($ /share)
Increase (decrease) in tax benefit arising from permanent differences.
Increase (Decrease) In Tax Benefit Arising From Permanent Differences
Permanent differences
Description Of Expected Term Of Share Options Granted
The expected term of the options (in years) at grant date used to calculate the fair value of share options granted.
Expected term (in years)
Current financial liabilities.
Current financial liabilities [member]
Current Financial Liabilities [member]
Not later than one year [member]
Less than One Year [member]
Vesting period
Vesting Period For Share Based Payment Arrangements
Describes whether the instruments granted in share-based payment arrangements vest in instalments over a specified period (aka graded vesting) or vest all at once on a specified date (aka cliff vesting).
Operating (expenses) and other operating income.
Operating (expenses) and other operating income
Total operating expenses and other operating income
The amount of provisions for employee litigation and serverance.
Provisions for employee litigation and serverance
Employee litigation and severance, Ending balance
Employee litigation and severance, Beginning balance
Interest accrued.
Interest Accrued
Interests accrued
Interest income on cash, cash equivalents and financial assets.
Interest income on cash, cash equivalents and financial assets
Income from cash, cash equivalents and financial assets
Other provision for charges used during the period.
Other Provision for Charges Used During The Period
Other provision for charges, Amounts used during the period
Segments [domain]
Classes of intangible assets and goodwill [domain]
Notional amount
Disclosure of deferred taxes [text block]
Disclosure of Deferred Tax Assets and Liabilities
Financial liabilities
Financial liabilities at end of period
Financial liabilities at beginning of period
Book value on the statement of financial position
Total financial liabilities
Book value on the statement of financial position
Diluted earnings loss per share from discontinued operations attributable to ordinary equity holders of parent entity.
Diluted Earnings Loss Per Share From Discontinued Operations Attributable To Ordinary Equity Holders Of Parent Entity
Diluted net income (loss) attributable to shareholders of Cellectis per share ($ /share) from discontinued operations
Cost of revenue
Cost of sales
Cost of revenue
Fair value of expected volatility amount.
Fair Value Of Expected Volatility Amount
Expected volatility
Fair value in $ thousands
Amount to be repaid.
Amount to be repaid
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]
Conditional Advances.
Conditional Advances [Member]
Disclosure of detailed information about fair value share price explanatory.
Disclosure Of Detailed Information About Fair Value Share Price [Text Block]
Fair value of Initial Investment Agreement at Initial Recognition Date Determined on Basis of Share Price
Tranche C Warrants [Member].
Tranche C Warrants [Member]
Cybersecurity Risk Management Third Party Engaged [Flag]
Financing Tax Receivble Percentage
Financing Tax Receivble Percentage
Financing tax receivble percentage
Cash and cash equivalents
Cash and cash equivalents at the end of the period
Cash and cash equivalents
Total cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Profit (loss) from operating activities
Operating income (loss)
Operating income (loss)
Operating income (loss) before tax
Cellectis S.A. [Member]
State guaranted loan.
State Guaranted Loan [Member]
Non-Current Portion of State-Guaranteed Loan
Non-Current Portion of State-Guaranteed Loan [Member]
Non-Current Portion of State-Guaranteed Loan
Accruals and deferred income including contract liabilities [abstract]
Tax expense (income) at applicable tax rate
Theoretical tax benefit (expense)
Assets [abstract]
ASSETS
The entire disclosure of trade receivables and other current assets Explanatory
Trade receivables and other current assets Explanatory
Trade receivables and other current assets
Geographical [Domain]
Gains on change in fair value of derivatives
Gain on change in fair value measurement recognized
Gain on change in fair value
Gain on fair value measurement
Disclosure of transactions between related parties [abstract]
Comprehensive income
Total Comprehensive income (loss)
Disclosure Of Number And Weighted Average Exercise Prices Of Share Options and Awards [Table]
Disclosure Of Number And Weighted Average Exercise Prices Of Share Options and Awards [Table]
Disclosure Of Number And Weighted Average Exercise Prices Of Share Options and Awards [Table]
Income taxes paid (refund), classified as operating activities
Income tax received (paid)
Proceeds from sale of preferred shares.
Proceeds From Sale Of Preferred Shares
Proceeds from sale of preferred shares
Conversion of notes receivable into trade receivable.
Conversion Of Notes Receivable Into Trade Receivable
Conversion of notes receivable into trade receivables
Research tax credit financings.
Research Tax Credit Financings [Member]
Research Tax Credit Financings [Member]
Other current liabilities1.
Other Current Liabilities 1- [Member]
Other Current Liabilities [member]
Financial liabilities at fair value through profit or loss, category [member]
Financial Liabilities at Fair Value through Profit or Loss, Category [Member]
Pension.
Pension [member]
Pension [member]
Deferred revenues.
Deferred revenues
Deferred revenues and contract liabilities
Deferred revenue
Adjustment for decrease (increase) in trade receivables and other current assets.
Adjustment for Decrease (Increase) in Trade Receivables and Other Current Assets
Decrease (increase) in trade receivables and other current assets
Number Of Share Options Exercisable Granted In Share Based Payment Arrangements
Number of share options exercisable granted in share based payment arrangements.
Option exercisable, granted
Consolidated operations [table].
Consolidated operations [table]
Consolidated operations [table]
Fair values per options.
Fair values per options
Fair value per options
Carrying amount [member]
Carrying amount [member]
Useful life measured as period of time, property, plant and equipment
Provisions for employee litigation and severance other comprehensive income.
Provisions For Employee Litigation And Severance Other Comprehensive Income
Employee litigation and severance, OCI
Office equipment [member]
Office Equipment [member]
Office and laboratory equipment [member]
Description of expected terms of years share options granted.
Description of expected terms of years share options granted
Expected term (in years)
Currency [Axis]
Total fair value
Total Fair Value
Fair value
Expected volatility
Increase Decrease on loan interest.
Increase Decrease on loan interest
Increase on loans interest
Servier [Member]
Servier
Equity Net Of Tax Weakening [Member]
Equity net of tax weakening.
Weakening
Lease liabilities
Lease debts
Total lease liabilities
Capital evolution 2024.
Capital Evolution 2024 [Member]
Capital Evolution 2024 [Member]
Intangible Assets [Abstract]
Intangible assets.
Cybersecurity Risk Management, Strategy, and Governance [Table]
Ending balance
Beginning balance
Net defined benefit liability (asset)
Net defined benefit liability (asset) at beginning of period
Net defined benefit liability (asset) at end of period
Intangible assets other than goodwill
Intangible assets other than goodwill at end of period
Intangible assets other than goodwill at beginning of period
Intangible assets
Total intangible assets other than goodwill
Revenue from performance obligations satisfied or partially satisfied in previous periods
Revenue from performance obligations satisfied or partially satisfied in previous periods
Accruals and deferred income including contract liabilities.
Accruals And Deferred Income Including Contract Liabilities [Line Items]
Foreign operations whose functional currency is not exchangeable into presentation currency [domain]
Proportion of voting rights held in associate
Voting rights held in associate
Amended and restated agreement.
Amended And Restated Agreement [Member]
Types of financial assets [domain]
Current value added tax payables
VAT Payables
Revenue and other operating income
Revenues and other income
Total revenues and other income
External revenues and other income
Weighted average exercise price of share options exercisable exercised in share based payment arrangements.
Weighted Average Exercise Price Of Share Options Exercisable Exercised In Share Based Payment Arrangements
Weighted- average exercise price per share, exercised
Document Shell Company Report
Accounting treatment of significant transactions
Description of Accounting Policy for Accounting Treatment of Significant Transactions of Period Explanatory
Description of accounting policy for accounting treatment of significant transactions of period explanatory.
Warrant exercise price
Warrant Exercise price
Exercise price
Cash and cash equivalent.
Cash and Cash Equivalent [member]
Cash and Cash Equivalents [member]
Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions
Actuarial gains and losses
Disclosure of non-adjusting events after reporting period [abstract]
Deferred Tax Assets Credits And Net Operating Loss Carryforwards
Deferred tax assets credits and net operating loss carryforwards.
Credits and net operating loss carryforwards
Adjustments for income tax expense
Income tax
Fair value of expected volatility amount plus five percentage.
Fair Value of Expected Volatility Amount Plus Five Percentage
Expected volatility +5%
June Twenty Six Thousand And Twenty Four [Member]
June twenty six thousand and twenty four.
06/26/2024 [member]
Subsidiaries [domain]
Disclosure of transactions between related parties [line items]
Proceeds from issue of share capital and other equity instruments after deduction of transaction costs
Proceeds from issue of share capital and other equity instruments after deduction of transaction costs.
Proceeds from issue of share capital and other equity instruments after deduction of transaction costs
Decrease in non current restricted cash due to reclassification in current assets.
Decrease In Non Current Restricted Cash Due To Reclassification In Current Assets
Decrease in restricted cash due to reclassification in current assets
Attribution of expenses by nature to their function [domain]
European Investment Bank Loan Tranche B.
European Investment Bank Loan - Tranche B [Member]
Exercise of share warrants and employee warrants shares, ( number of shares ).
Exercise of share warrants and employee warrants shares
Exercise of share warrants, employee warrants, stock-options and free-shares, shares
Exercise of share warrants, employee warrants, stock-options and free-shares vesting, shares
Provision for tax litigation.
Provision For Tax Litigation
Provision for tax litigation, Ending balance
Provision for tax litigation, Beginning balance
Provision for tax litigation, Biginning balance
Foreign currencies
Description of accounting policy for foreign currency translation [text block]
Disclosure of non-adjusting events after reporting period [line items]
Bpifrance.
Bpifrance [Member]
BPI [Member]
Actuarial assumption of expected rates of salary increases
Salary increases
Profit (loss) before tax
Profit (loss) before tax
Income (loss) before taxes from continuing operations
Proportion of ownership interest in subsidiary
Ownership interest in subsidiary
Ownership interest
Effects Of Profit And Loss And Equity Net Of Tax [Domain]
Effects of profit and loss and equity net of tax.
License agreement with Servier.
License Agreement with Servier [Member]
License Agreement with Servier [Member]
Milestone Payment
Milestone payment
Milestone Payment
Revenue
External revenues
Total revenues
Revenues
Diluted net income (loss) attributable to shareholders of Cellectis per share ($ /share) from discontinued operations
Diluted earnings from discontinued operations per share ( $ /share)
Diluted net income (loss) attributable to shareholders of Cellectis from discontinued operations, per share ($ /share)
Allocation of prior period gain (loss)
Allocation Of Prior Period Gain (Loss)
Allocation of prior period loss
Disclosure of financial assets and liabilities table.
Disclosure Of Financial Assets And Liabilities [Table]
Disclosure Of Financial Assets And Liabilities [Table]
Commercial litigation amounts used during the period.
Commercial Litigation Amounts Used During The Period
Commercial litigation, Amounts used during the period
Description of accounting policy for segment reporting [text block]
Segment reporting
Call Options February Twenty Fifth Two Thousand And Twenty Six [member]
Call options february twenty fifth two thousand and twenty six.
Call options
Cash flows from (used in) operating activities
Net cash flows provided by (used in) operating activities
Net cash flows from (used in) operating activities
Deferred Tax Liabilities Right Of Use Assets And Other Leases Related Effects
Deferred tax liabilities right of use assets and other leases related effects.
Right-of-use assets and other leases-related effects
European Investment Bank Loan Tranche A.
European Investment Bank Loan - Tranche A [Member]
Types of financial assets [axis]
Liabilities
Liabilities at end of period
Liabilities at beginning of period
Total liabilities
Total liabilities
Liabilities
Deferred expenses and other current assets.
Deferred Expenses And Other Current Assets
Deferred expenses and other current assets
Other operating expenses
Other Operating Expenses
Other operating expenses
Disclosure of net defined benefit liability (asset) [abstract]
Fair value of expected life of derivative plus one month
Fair value of expected life of derivative plus one month.
Expected life of derivative +1 month
Non-current assets or disposal groups classified as held for sale
Assets held for sale
Non Current provisions other comprehensive income.
Non Current provisions other comprehensive income
Non current provisions OCI
Disclosure of Scope of consolidation and non-consolidated entities.
Disclosure Of Scope Of Consolidation and Non-Consolidated Entities [Abstract]
Decrease in purchases and external expenses
Decrease in purchases and external expenses
Transaction costs disbursed in cash
Transaction costs.
Transaction Costs
Transaction costs
Decrease increase through tax on sharebased payment transactions equity and other IFRS adjustments.
Decrease Increase Through Tax On Sharebased Payment Transactions Equity And Other IFRS Adjustments
Share-based compensation & other IFRS adjustments
Provisions [abstract]
Theoretical group tax rate
Applicable tax rate
Applicable tax rate
Disclosure Of Detailed Information About Breakdown Of Right Of Use Assets Explanatory
Disclosure Of Detailed Information About Breakdown Of Right Of Use Assets Explanatory
Disclosure Of Detailed Information About Breakdown Of Right Of Use Assets Explanatory
Entity Well-known Seasoned Issuer
Increase In The Number Of Shares Granted
Increase in the number of shares granted
Increase in the number of shares granted
August Four Two Thousand Twenty Five [Member]
August four two thousand twenty five.
8/4/2025 [member]
Increase in net defined benefit liability in discount rate.
Increase In Net Defined Benefit Liability In Discount Rate
Increase in net defined benefit liability in discount rate
Impairment loss
Impairment of assets
Tranche A And Tranche B Warrants [Member]
Tranche A and Tranche B warrants.
Net foreign exchange loss
Net foreign exchange loss
Foreign exchange losses
Convertible Notes
Convertible Notes [Member]
Number of operating and reportable segments.
Number of Operating and Reportable Segments
Number of operating and reportable segments
Increase in non current deposits.
Increase In Non Current Deposits
Increase in non current deposits
Current financial assets and cash and cash equivalent.
Current Financial Assets And Cash And Cash Equivalents
Current financial assets and cash and cash equivalents
Current deferred income including current contract liabilities
Deferred income and contract liabilities
Total Deferred revenue and contract liabilities
Deferred revenues and contract liabilities
Additions other than through business combinations, property, plant and equipment
Additions
Discontinued operations [member]
Discontinued operations [member]
Miscellaneous other operating expense
Other operating expenses
Adjustments for provisions
Provisions
October one three two thousand twenty one
October one three two thousand twenty one [Member]
10/13/2021 [member]
Amendment Flag
Amendment Flag
Decrease in research and development expense.
Decrease in Research and Development Expense
Decrease in research and development expense
Income loss.
Income (loss) [member]
Disclosure of share capital, reserves and other equity interest [text block]
Capital
Percentage Of Fair Market Value
Percentage of fair market value.
Percentage of market value
Disclosure of detailed information about property, plant and equipment [line items]
Disclosure of detailed information about property, plant and equipment [line items]
Interest expense for financial liabilities not at fair value through profit or loss
Interest on financial liabilities
Interest on financial liabilities
Current liabilities other [member]
Current liabilities other.
March fifth two thousand and twenty one tranch one [Member].
March Fifth Two Thousand And Twenty One [Member]
03/05/2021 [member]
Borrowings by name [domain]
Classes of intangible assets and goodwill [axis]
Classes of intangible assets and goodwill [axis]
Number of other equity instruments forfeited in share-based payment arrangement
Option outstanding, forfeited, cancelled or expired
Entity Address, Postal Zip Code
Non Recognition Of Deferred Tax Assets
Non recognition of deferred tax assets.
Non-recognition of deferred tax assets
Categories of related parties [domain]
NORTH CAROLINA
Raleigh, North Carolina [Member]
Collaboration Agreement Payment Reallocated.
Collaboration Agreement Payment Reallocated
Collaboration agreement payment reallocated
Major customers [axis]
Patents [Member]
Copyrights, patents and other industrial property rights, service and operating rights [member]
Cybersecurity Risk Role of Management [Text Block]
Current restricted cash and cash equivalents
Restricted cash
Short term restricted cash
Right-of-use assets [member]
Right-of-Use Asset
The amount of revenue from collaboration agreements.
Revenue From Collaboration Agreements
Collaboration agreements
Collaboration agreements
Revenue from collaboration agreements
Retained earnings, profit (loss) for reporting period
Net income (loss)
Cellectis, Inc. [Member]
Cellectis Inc [Member]
Cellectis [member]
Cellectis, Inc. [Member]
Number of voting rights
Number of voting rights.
Number of voting rights
Entity Address, Address Line One
State Operating Loss Carryforwards Expiration Year
State operating loss carryforwards expiration year.
State operating loss carryforwards expiration year
Non-controlling interests [member]
Non controlling Interests [member]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]
Amendment agreement one.
Amendment Agreement One [Member]
Amendment Agreement One [Member]
Disclosure of revenue by nature explanatory.
Disclosure of revenue by nature explanatory [table text block]
Revenues by Nature
The method used to estimate the fair value of an asset or a liability.
Valuation Method
Valuation method
Intangible assets and goodwill gross.
Intangible assets and goodwill gross
Gross value at end of period
May Twenty Four Two Thousand and Twenty Two [Member]
May Twenty Four Two Thousand and Twenty Two.
05/24/2022 [member]
Later than five years [member]
More than Five Years [member]
Warrants grant date.
Warrants Grant Date
Grant date
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
Ordinary shares issued
Ending balance, shares
Beginning balance, shares
Number of shares issued
Total number of shares issued
Number of shares to be issued
Unobservable inputs [axis]
Proceeds from sale of ordinary shares.
Proceeds From Sale Of Ordinary Shares
Proceeds from sale of ordinary shares
Proceeds received
12/19/2022 [member]
December Nineteen Two Thousand and Twenty Two [Member]
December Nineteen Two Thousand and Twenty Two.
Disclosure of income tax [text block]
Disclosure of Income Tax
Cash and cash equivalents in subsidiary or businesses acquired or disposed
Calyxt's cash and cash equivalents disposed of
The decrease in contract liability balances resulting from the transfer of goods or services to customers.
Decrease due to Revenue Recognition, Contract Liabilities
Decrease due to revenue recognition
Contact Personnel Fax Number
March twenty seven two thousand fifteen.
March twenty seven two thousand fifteen [member]
3/27/2015 [member]
Document Type
Document Type
Development milestone received.
Development milestone received
Weighted Average Exercise Price Of Share Options Additional Shares Due To May Twenty Twenty Four Sharebased Payment Arrangement 2019
Weighted Average Exercise Price Of Share Options Additional Shares Due To May Twenty Twenty Four Sharebased Payment Arrangement 2019
Weighted average exercise price per share, additional shares due to May 2024 modification
Percentage of Revenue
Percentage of entity's revenue
Operating expense
Operating expenses
Total operating expenses and other operating income
Estimated fair value.
Estimated Fair Value [Member]
Estimated Fair Value [member]
Rights, preferences and restrictions attaching to class of share capital
Conversion ratio
Conversion ratio description
Stock option.
Stock Option 1 [Member]
Stock options [member]
Weighted average exercise price of share options exercisable forfeited or expired in share based payment arrangements.
Weighted Average Exercise Price Of Share Options Exercisable Forfeited Or Expired In Share Based Payment Arrangements
Weighted- average exercise price per share, forfeited or expired
Weighted- average exercise price per share, forfeited or expired
Cash flows from (used in) investing activities
Net cash flows from (used in) investing activities
Cash flows provided by (used in) investment activities
Disclosure of material accounting policy information [text block]
Accounting principles
Disclosure of other current liabilities [text block]
Other current liabilities
Entity Central Index Key
Entity Central Index Key
Interest cost
Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)
Total current financial assets at fair value through profit or loss
Current financial assets at fair value through profit or loss
Fair value other current assets
Research tax credit litigations accrual
Research Tax Credit Litigations Accrual
Research tax credit litigations accrual.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
Bottom of range [member]
Bottom of Range [member]
The increase (decrease) in contract liability balances resulting from changes in foreign exchange rates.
Increase (decrease) Through Changes in Foreign Exchange Rates, Contract Liabilities
Revenue from positive foreign exchange impact, partially offset
Miscellaneous other operating income
Other operating income
Federal R&D tax credits, expiration period
Research and Development Tax Credits, Tax Effect of Tax Losses, Expiration Period
Research and development tax credits, tax effect of tax losses, expiration period.
Cytovia agreement.
Cytovia Agreement [Member]
Cytovia Agreement [Member]
Put Option May Thirteenth Two Thousand And Twenty Five [Member]
Put option may thirteenth two thousand and twenty five.
Put options
Continuing and discontinued operations [axis]
Provision for tax litigation additions.
Provision For Tax Litigation Additions
Provision for tax litigation, Additions
Geographical areas [axis]
Geographical areas [axis]
Increase (decrease) in working capital
Change in working capital
Current financial assets.
Current Financial Assets [member]
Current Financial Assets [member]
Borrowings
Total borrowings
Borrowings
Aggregate credit facility.
Aggregate credit facility
Percentage of voting equity interest
Percentage of voting equity interest.
Agreement one.
Agreement One [Domain]
Disclosure of basis of consolidation and material accounting policy information explanatory.
Disclosure Of Basis Of Consolidation And Material Accounting Policy Information Explanatory
Basis for preparation
Collaboration agreement.
Collaboration Agreement [domain]
Current Portion of State-Guaranteed Loan
Current Portion of State-Guaranteed Loan [Member]
Associates [domain]
Cash received
Cash received related to increase (decrease) in working capital
Cash received related to increase (decrease) in working capital.
Grant Date [Axis]
Grant date.
Class A and B Preferred Shares [Member]
Class A and B Preferred Shares.
Class A and B Preferred Shares
Fixed term bank deposit maturity period.
Fixed Term Bank Deposit Maturity Period
Fixed term bank deposit, maturity period
Operating expense.
Operating Expense [Abstract]
Operating expenses
Retained earnings [member]
Retained Earnings (Deficit) [member]
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss
Depreciation & impairment expense
Total depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss
Depreciation & impairment expense
The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualized standard deviation of the continuously compounded rates of return on the share over a period of time.
Expected Volatility
Document Financial Statement Error Correction [Flag]
Categories of financial assets [domain]
Financial Liabilities And Lease Debts
Financial liabilities and lease debts.
Total Financial liabilities and lease debts
March twenty four two thousand fifteen.
March twenty four two thousand fifteen [member]
3/24/2015 [member]
Weighted Average Fair Value At Measurement Date Other Equity Instruments Forfeited
The weighted average fair value at the measurement date of other equity instruments (ie other than share options) expired or forfeited in a share-based payment arrangement. [Refer: Weighted average [member]"
Weighted average exercise price per share, Cancelled
Fair Value Instrument Remeasured
Fair value instrument remeasured.
Share issuance price.
Share Issuance Price
Share issuance price
Receivables.
Receivables1 [abstract]
Put Options February Twenty Fifth Two Thousand And Twenty Six [member]
Put options february twenty fifth two thousand and twenty six.
Put options
Provision Of Reversal Tax Litigation
Provision of reversal tax litigation.
Provision of reversal tax litigation
Proceeds from issue of ordinary shares
Exercise stock option
Tranche A Warrants.
Tranche A Warrants [Member]
Disclosure of revenue [text block]
Disclosure of subsidiaries [abstract]
Related party transactions [abstract]
Ownership [Domain]
Current Fiscal Year End Date
Current Fiscal Year End Date
Current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners
Total current assets
Other operating income
Other Operating Income1
Other operating income
Increase Decrease in interest income from cash, cash equivalents and financial assets.
Increase Decrease in interest income from cash, cash equivalents and financial assets
Decrease /increase in income from cash, cash equivalents and financial assets
Profit (loss) from discontinued operations attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share
Net income (loss) attributable to shareholders of Cellectis from discontinued operations (in thousands)
Research Tax Credit Litigation Settled
Research Tax Credit Litigation Settled
Research tax credit litigation settled
Astra Zeneca.
Astra Zeneca [Member]
AstraZeneca [member]
Interest expense on EIB loan
Interest expense on bank loans and overdrafts
Expenses by nature [abstract]
Operating expenses
Increase (decrease) in cash and cash equivalents, discontinued operations
(Decrease) increase in cash and cash equivalents
Other non-current financial liabilities
Non-current financial liabilities
Maturity by Grant Date [Domain]
Maturity by grant date.
Grant Date [Domain]
Equity investments [member]
Schedule Of Cash Flow Statement Of Discontinued Operations
Schedule Of Cash Flow Statement Of Discontinued Operations [Table Text Block]
Schedule Of Cash Flow Statement Of Discontinued Operations
Disclosure of impairment loss and reversal of impairment loss [abstract]
Cash flows from (used in) investing activities, discontinued operations
Net cash flows provided by (used in) investing activities of discontinued operations
Net cash flows from (used in) investing activities, discontinued operations
Types of financial liabilities [domain]
Increase in personnel expenses
Increase In Personnel Expenses
Increase in personnel expenses
Accumulated tax losses
Accumulated Tax Losses
Accumulated tax losses.
Income Tax effect on share-based compensation
Income tax effect on share-based compensation.
Tax effect on share-based compensation
Current liabilities
Current liabilities
Total current liabilities
Current liabilities
Other non-current financial liabilities.
Other non-current financial liabilities [member]
Other Non-Current Financial Liabilities [member]
Warrants [member]
Warrants [Member]
July Twenty Two Thousand and Twenty [Member]
July twenty two thousand and twenty.
07/20/2020 [member]
Geographical [Axis]
Class Of Warrants Or Right [Axis]
Agreement two
Agreement Two [Axis]
Adjustments for increase (decrease) in deferred revenue and contract liabilities to reconcile profit (loss) to net cash flows provided by (used in) operating activities.
Adjustments For Increase Decrease In Deferred Revenue And Contract Liabilities
(Decrease) increase in deferred revenues and contract liabilities
Finance income (cost)
Net financial gain (loss)
Net Financial gain (loss)
Net Financial gain (loss)
Net Financial gain (loss)
Key management personnel compensation share based payments in shares.
Key management personnel compensation share based payments in shares
Key management personnel compensation, share-based payments in shares
Non-adjusting events after reporting period [axis]
Disclosure of trade and other receivables [text block]
Disclosure of Trade Receivables
Decrease in foreign exchange gains (losses)
Decrease in foreign exchange gains losses.
Decrease In Foreign Exchange Gains Losses
Disclosure of revenue and other income explanatory.
Disclosure Of Revenue And Other Income Explanatory [TableTextBlock]
Revenues By Country of Origin and Other Income
Classes of financial liabilities [domain]
Increase (decrease) in accruals for personnel related expenses.
Increase (Decrease) in Accruals for Personnel Related Expenses
Decrease in accruals for personnel related expenses
Number of other equity instruments expired in share-based payment arrangement
Number of instruments voided
Number of instruments voided
Disclosure of expected impact of initial application of new standards or interpretations [line items]
Disclosure of changes in accounting estimates [line items]
Number of Free shares Vested
Number of free shares vested.
Share price warrants.
Share Price Warrants
Share price
Short-term deposits, not classified as cash equivalents
Current financial assets
Deposit
Percentage change sensistivity
Percentage Change Sensistivity
Percentage change sensistivity.
Deferred Tax Liabilities Accelerated Depreciation Of Assets For Tax Purposes
Deferred tax liabilities accelerated depreciation of assets for tax purposes.
Accelerated depreciation of assets for tax purposes
September Five Thousand And Twenty Four [Member]
September five thousand and twenty four.
09/05/2024 [member]
Current lease debts [Member]
Current lease debts [Member]
Current Lease Debts [member]
Weighted average fair value at measurement date share options granted per share.
Weighted Average Fair Value at Measurement Date Share Options Granted Per share
Weighted-Average fair values of warrants granted
Weighted-Average fair values of stock options granted
Amount convertible note due and payable in full cash.
Amount Convertible Note Due and Payable in Full Cash
Amount of convertible note due and payable in full cash
The amount of Provisions for employee litigation and severance additions.
Provisions for employee litigation and severance additions
Employee litigation and severance, Additions
Joint research and collaboration agreement, initial investment agreement, subsequent investment agreement.
Joint Research And Collaboration Agreement Initial Investment Agreement Subsequent Investment Agreement [Member]
AZ JRCA, IIA and SIA [Member]
Non-current financial liabilities
Non-current financial liabilities
Total non-current financial liabilities
Borrowings
Retirement age.
Retirement Age
Retirement age
Fair value of warrants.
Fair value
Fair value of warrants
Fair value of pre funded warrants
Disclosure of detailed information about financial instruments [text block]
Financial assets and liabilities
Agreement Axis and License.
Agreeement [Axis]
Classes of liabilities [axis]
Interest paid, classified as financing activities
Interest expense
Interest paid on financial debt
Interest paid
Gain in fair value of foreign exchange derivatives.
Gain In Fair Value Of Foreign Exchange Derivatives
Gain in fair value of foreign exchange derivatives
Weighted average exercise price per share, cancelled, forfeited or expired
Weighted average exercise price per share, forfeited or expired
Weighted average exercise price per share, cancelled, forfeited or expired
Weighted average exercise price per share
Increase (decrease) in net defined benefit liability (asset) resulting from past service cost
Past service cost
Unrealized Gains Losses [Member]
Unrealized Gains Losses [Member]
Unrealized Gains Losses [Member]
Net deferred tax liabilities
Net deferred tax liabilities
Non-Cash Stock Based Compensation Expense Due To Change In Ratio Conversion
Non-cash stock based compensation expense due to change in ratio conversion.
Additional stock-based compensation expense
Range [axis]
Range [axis]
Other comprehensive income that will not be reclassified to profit or loss net of tax from continuing operations.
Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net Of Tax From Continuing Operations
Other comprehensive income (loss) that will not be reclassified subsequently to income or loss from continued operations
Deferred tax assets accumulated tax loss carryforwards and federal research and development tax credits
Deferred tax assets accumulated tax loss carryforwards and federal research and development tax credits.
Deferred tax assets related to accumulated tax loss carryforwards and federal R&D tax credits
Disclosure of offsetting of financial liabilities [line items]
Disclosure of offsetting of financial liabilities [line items]
Disclosure of offsetting of financial liabilities [line items]
Number Of Exercisable Share Options Exercised In Share Based Payment Arrangement
Number of exercisable share options exercised in share based payment arrangement.
Option exercisable, exercised
Option Outstanding, exercised
Shares, Vested
Forfeited or Expired
Warrants outstanding, exercised
Option outstanding, exercised
Cash flows from (used in) investing activities [abstract]
Cash flows from investment activities
Shares entitlement per option.
Shares Entitlement per Option
Share entitlement per option
NovemberFiveTwoThousandTwenty [Member]
11/05/2020 [member]
Novemberfivetwothousandtwenty Member
Segments [axis]
other subsidies amount.
Other Subsidies Amount
Other subsidies and other
06/26/2023 [member]
June Twenty Six Two Thousand And Twenty Three [Member]
June twenty six two thousand and twenty three.
October eleven two thousand seventeen.
October eleven two thousand seventeen [member]
10/11/2017 [member]
Decrease (increase) in trade receivables and other current assets
Adjustments for decrease (increase) in trade and other receivables
Discontinued Operations
Discontinued Operations [Abstract]
Discontinued Operations [Abstract]
Weighted average exercise price of share options exercisable in share-based payment arrangement
Weighted- average exercise price per share, ending balance
Weighted- average exercise price per share, beginning balance
Trade and other receivables [abstract]
Increase decrease in Income from cash, cash equivalents and financial assets
Increase decrease in Income from cash, cash equivalents and financial assets
Increase (decrease) in Income from cash, cash equivalents and financial assets
Profit (loss), attributable to ordinary equity holders of parent entity
Net income (loss) attributable to shareholders of Cellectis (in thousands)
Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share
Disclosure of financial liabilities [line items]
Calyxt Inc.
Calyxt Inc [Member]
Calyxt Inc. [Member]
Interest received, classified as operating activities
Interest received
Financial liabilities, at fair value
Fair value
Fair value of financial liabilities
Disclosure of terms and conditions of share-based payment arrangement [table]
Disclosure of terms and conditions of share-based payment arrangement [table]
Number of shares entitled per option.
Number Of Shares Entitled Per Option
Share entitlement per option
Share entitlement per warrant
Current loans received and current portion of non-current loans received
Current liability of loan
Classes of financial liabilities [axis]
Classes of financial liabilities [axis]
Number of other equity instruments granted in share-based payment arrangement
Option outstanding, granted
Number shares granted
Earnings per share [abstract]
Basic / Diluted net income (loss) per share attributable to shareholders of Cellectis
Lease agreement term.
Lease Agreement Term
Lease agreement term
Disclosure of current financial assets and cash and cash equivalents.
Disclosure Of Current Financial Assets And Cash And Cash Equivalents [Line Items]
Disclosure of current financial assets and cash and cash equivalents [line items]
Equity attributable to owners of parent [member]
Attributable to Shareholders of Cellectis [member]
Provisions for retirement indemnities amounts used during the period.
Provisions For Retirement Indemnities Amounts Used During The Period
Retirement indemnities , Amounts used during the period
Annual limit to carryforwards use against future taxable profit amount
Annual Limit To Carryforwards Use Against Future Taxable Profit Amount
Annual limit to carryforwards use against future taxable profit amount.
Classes of intangible assets other than goodwill [domain]
Disclosure of information about assumptions used and valuation results.
Disclosure of information about assumptions used and valuation results [text block]
Summary of Assumptions Used and Estimated Fair Value
Unobservable inputs [domain]
Gain (loss) on fair value measurement
Gain Loss on Fair Value Measurement
Gain loss on fair value measurement.
Research Tax Credit Subsidy Amount
Research tax credit subsidy amount.
Research tax credit subsidy
Research tax credit.
Research Tax Credit
Research tax credit
Change in fair value.
Change in Fair Value
Change in fair value
Advances received, representing contract liabilities for performance obligations satisfied at point in time
Conditional advance
Tax effect on change in fair value of certain financial instruments
Income Tax effect on change in fair value of financial instruments
Income Tax effect on change in fair value of financial instruments.
Schedule of Breakdown Of Right Of Use Assets [Abstract].
Schedule of Breakdown Of Right Of Use Assets [Abstract]
Other comprehensive income, reclassification adjustment on deconsolidation of merged entity.
Other comprehensive income, reclassification adjustment on deconsolidation of merged entity
OCI Reclassification pursuant to Calyxt's deconsolidation
Disclosure of property, plant and equipment [text block]
Property, plant and equipment
March Twenty Two Two Thousand And Twenty Three [Member]
March twenty two two thousand and twenty three.
03/22/2023 [member]
Comprehensive income, attributable to owners of parent
Attributable to shareholders of Cellectis
Total comprehensive income, attributable to owners of parent
Adjustments for finance income (cost)
Net financial loss (gain)
Disclosure of disaggregation of revenue from contracts with customers [text block]
Revenues by Nature
November Six Two Thousand Nineteen.
November Six Two Thousand Nineteen [Member]
11/06/2019 [member]
Milestone [Domain]
Operation between shareholder
Operation between shareholder.
Operation between shareholders
Consolidated operations.
Consolidated operations [abstract]
Cellectis.
Cellectis [Member]
Cellectis [member]
Cellectis [Member]
Current derivative financial assets
Derivatives
Exercise price, share options granted
Exercise price
Disclosure of basis of consolidation [text block]
Information concerning the Group's Consolidated Operations
Scope of consolidation and non-consolidated entities
Disclosure of detailed information about property, plant and equipment [text block]
Details of Property, Plant and Equipment
Disclosure of impairment of assets [text block]
Impairment tests
Auditor Firm ID
Option vesting period.
Option Vesting Period
Vesting period, years
Lease option to extend lease agreement.
Lease Option To Extend Lease Agreement
Lease option to extend lease agreement.
Lease option to extend lease agreement
Intangible assets other than goodwill estimated useful life.
Intangible Assets Other than Goodwill Estimated Useful Life
Estimated useful lives
Terms of repayment.
Terms of Repayment
Terms of repayment
Types of warrants [Axis]
Types of warrants [Axis]
Revaluations of financial assets
Deferred Tax Assets Revaluations Of Financial Assets
Deferred tax assets revaluations of financial assets.
Disclosure of assumption used to estimate fair value of warrants.
Disclosure of Assumptions Used to Estimate Fair Value of Warrants [Text Block]
Summary of assumptions Weighted-average Fair Values of Warrants Granted and Assumptions Used for Black-Scholes Option Pricing Model
Research Tax Credit financing
Research Tax Credit Financing [Member]
Disclosure of reconciliation of liabilities arising from financing activities [abstract]
Deferred tax liabilities from other taxable differences
Deferred Tax Liabilities From Other Taxable Differences
Deferred tax liabilities from other taxable differences.
Financial Institution [Axis]
Disclosure of financial liabilities [table]
Wages and salaries
Wages and salaries
The amount of commercial litigations.
Commercial Litigations
Commercial litigation, Ending balance
Commercial litigation, Beginning balance
Commercial litigation
Current service cost
Increase in net defined benefit liability (asset) resulting from current service cost
Milestone achievement related to dosing of first subject in phase I.
Milestone Achievement Related to Dosing of First Subject in Phase I [Member]
Milestone Achievement Related to Dosing of First Subject in Phase I [Member]
Summary Of Cash And Cash equivalents And Current Financial Assets Denominated In United States Dollars Affected Equity And Profit Or Loss [Table Text Block]
Summary of cash and cash equivalents and current financial assets denominated in united states dollars affected equity and profit or loss.
Summary of Cash, Cash Equivalents and Current Financial Assets Denominated in US Dollars Affected Profit or Loss and Equity
Research tax credit receivable.
Research Tax Credit Receivable
Research tax credit receivable
Research tax credit receivables
Equity and liabilities
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
Class A Preferred shares with single voting rights [Member]
Class A Preferred shares with single voting rights.
Class A Preferred shares with single voting rights [Member]
Disclosure of information about consolidated and non-consolidated structured entities.
Disclosure Of Information About Consolidated And Non-consolidated Structured Entities [Table]
Foreign exchange loss
Foreign exchange loss
Foreign exchange losses
Foreign exchange loss
Additions to right-of-use assets
Additions
Agreement Axis
Agreement [Axis]
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Types of antidilutive instruments [domain]
Disclosure of analysis of single amount of discontinued operations [table]
Liabilities included in disposal groups classified as held for sale
Liabilities related to asset held for sale
Vesting Of Free Shares And Stock Option Exercises Value
The increase (decrease) in shareholders' equity through the issue of equity instruments resulting from the vesting of free shares and the exercises of stock-options granted to employees and directors in share-based payment arrangements.
Exercise of share warrants, employee warrants, stock-options and free-shares vesting, amount
Finance income
Financial income
Financial income
Document Information [Line Items]
Adjustments for share-based payments
Expenses related to share-based payments
Adjustments for share-based payments, Total
Transactions costs
Payments for share issue costs
Type
Type of equity instrument granted
Type of equity instrument granted.
Expected volatility less five percent.
Expected Volatility Less Five Percent [Member]
Expected volatility -5% [Member]
Non-current financial liabilities.
Non-current financial liabilities [member]
Other non current financial liabilities [member]
Warrant expiration date.
Warrant Expiration Date
Expiration date
Significant unobservable input, liabilities
Percentage of grant and refundable advance
Collaboration agreement upfront payment received
Collaboration Agreement Upfront Payment Received
Collaboration agreement, upfront payment received
Non-current financial assets
Non-current financial assets
Non current financial assets
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
Profit from deconsolidation
Income (loss) from discontinued operations
Net income (loss) from discontinued operations
Net loss for the period from discontinued operations
Provisions for retirement indemnities other comprehensive income.
Provisions For Retirement Indemnities Other Comprehensive Income
Retirement Indemnities , OCI
Percentage of debt repayment terms
Percentage of debt repayment terms
The risk-free rate represents the interest an investor would expect from an absolutely risk-free investment over a specified period of time.
Risk Free Interest Rate
Risk-free interest rate
Risk free rate
Document Registration Statement
Other comprehensive income, before tax, gains (losses) on remeasurements of defined benefit plans
Total other comprehensive income, before tax, gains (losses) on remeasurements of defined benefit plans
Actuarial gains (losses)
Capital requirements [axis]
Capital requirements [axis]
Derivative Instruments Maturity Date
Derivative instruments maturity date.
Provisions for retirement indemnities additions.
Provisions For Retirement Indemnities Additions
Retirement indemnities , Additions
Current lease liabilities
Current lease debts
Lease debts
Clinical And Rd Agreements Member
Clinical And RD Agreements [Member]
Clinical & Research and Development agreements [member]
Deferred income including contract liabilities
Deferred income and contract liabilities
Total deferred income and contract liabilities
Classes of share capital [domain]
Deposit and financial investments
Non-current financial assets
Deposit
The fair value of the Company's common shares.
Company share price
Share price
Financial liabilities excluding EIB warrant liability.
Financial Liabilities Excluding EIB Warrant Liability
Financial liabilities excluding EIB warrant liability
Cibus shares.
Cibus shares [Member]
Cibus Shares [Member]
Profit And Loss Weakening [Member]
Profit and loss weakening.
Weakening
Non-Recurring Gains (Losses) On Financial Assets At Fair Value Through Profit Or Loss
Non-recurring gains (losses) on financial assets at fair value through profit or loss.
Non-recurring gain (loss) in fair value measurement before derecognition
Business Contact [Member]
Defined benefit plans [domain]
Total upfront payments
Total upfront payments
Disclosure of share-based payment arrangements [text block]
Non-cash stock-based compensation
Share-based payments
Disclosure of provisions [text block]
Provisions
AugustFiveTwoThousandTwenty [Member]
08/05/2020 [member]
Augustfivetwothousandtwenty Member
Disclosure of detailed information about intangible assets [line items]
Disclosure of terms and conditions of share-based payment arrangement [abstract]
Expense from share-based payment transactions with employees
Share based payment expense
Share-based compensation expense
Non-cash stock based compensation expense
Reserve of exchange differences on translation [member]
Currency Translation Adjustment [member]
UNITED STATES
United States [member]
US
Social security contributions on stock option grants.
Social Security Contributions On Stock Option Grants
Social charges on stock option grants
Classes of share capital [axis]
Classes of share capital [axis]
Types of share-based payment arrangements [domain]
Variable consideration amount.
Variable consideration amount
Variable consideration amount
Increase (decrease) through transfer between retained earnings into share premium.
Increase Decrease Through Transfer Between Retained Earnings Into Share Premium
Increase (decrease) through transfer between retained earnings into share premium
Step up interest rate percentage on notes receivable.
Step Up Interest Rate Percentage On Notes Receivable
Step up interest rate percentage on notes receivable
Number of ordinary shares received.
Number Of Ordinary Shares Received
Number of common stock received
Fair value of expected volatility amount less five percentage.
Fair Value of Expected Volatility Amount Less Five Percentage
Expected volatility -5%
Proportion of ownership interest
Proportion of Ownership Interest
Proportion of ownership interest.
Ownership interest
Major customers [domain]
Volatility
Volatility [Member]
Volatility.
Disposal
Disposals of right of use assets.
Disposals Of Right Of Use Assets
Disposals of right-of-use assets
Disclosure of financial assets and liabilities.
Disclosure of Financial Assets And Liabilities [Line Items]
Disclosure of financial assets and liabilities [line items]
Share issue related cost
Transaction costs
Share issuance related cost
Transaction costs
Transaction costs related to capital increase
Disclosure of Sensitivity of the derivative fair value to the expected life of the derivative [text block]
Disclosure of sensitivity of the derivative fair value to the expected life of the derivative.
Schedule of Sensitivity of Derivative Fair Value to Expected Life of Derivative
Profit (loss), attributable to owners of parent
Attributable to shareholders of Cellectis
Net income (loss) attributable to shareholders of Cellectis
Other financial liabilities
Financial liabilities
Other financial liabilities
The percentage of the certain Research Tax Credit Receivables subject to a prefinancing.
Percentage of financing tax receivable related to research tax credit
Noncurrent Financial Liabilities and Noncurrent Lease Debts Proceeds from Debts
Noncurrent financial liabilities and noncurrent lease debts proceeds from debts.
Proceeds from new debts non-current financial liabilities and non-current lease debts
Interest expense on lease liabilities
Interest on lease liabilities
Disclosure of Non-current Financial Assets Explanatory [Text Block]
The enitre disclosure of non-current financial assets explanatory.
Non-current financial assets and Other non-current assets
Other expenses, by nature
Other expenses
Other
Other expenses
Equity attributable to owners of parent
Equity value
Total shareholders' equity - Group Share
Capital commitments [abstract]
Current financial assets
Current financial assets
Total current financial assets
Deposit
May Four Two Thousand And Twenty Three [Member]
May four two thousand and twenty three
05/04/2023 [member]
Computer Software [Member]
Computer software [member]
Software and patents.
Software And Patents [Member]
Software and Patents [member]
Current secured bank loans received and current portion of non-current secured bank loans received
Current liability
Put Option July Eleventh Two Thousand And Twenty Five [Member]
Put option july eleventh two thousand and twenty five.
Put options
Entity [Domain]
Entity [Domain]
Adjustments for increase decrease in deferred revenues and contract liabilities.
Adjustments for increase decrease in deferred revenues and contract liabilities
Increase in deferred revenues and contract liabilities
Name of associate
Name of associate
Initial fair value of loan.
Initial Fair Value Of Loan
Initial fair value of the loan
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]
Provision for tax litigation member.
Provision For Tax Litigation [Member]
Provision for tax litigation [Member]
Increase (decrease) in non-cash stock based compensation expense.
Increase (Decrease) in Non-cash Stock Based Compensation Expense
Increase in non-cash stock-based compensation expense
Decrease in non-cash stock based compensation expense
Deconsolidation of merged entity
Deconsolidation of merged entity
Loss of control over Calyxt
Increase In Selling General And Administrative Expenses
Increase In Selling General And Administrative Expenses
Increase in selling, general and administrative expenses
Cellectis biologics, Inc.
Cellectis Biologics Inc [Member]
Cellectis Biologics, Inc. [Member]
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]
Loss in financial expenses
Loss in financial expenses.
License and Collaboration Agreements [Member]
License and Collaboration Agreements [Member]
License and Collaboration Agreements [Member]
Selling, general and administrative expense
Total selling, general and administrative expense
Selling, general and administrative expenses
Total selling, general and administrative expenses
04/24/2019 [member]
April Twenty Four Two Thousand Nineteen [Member]
April twenty four two thousand nineteen.
Derivatives by name.
Derivatives By Name [Axis]
Finance Advance
Finance Advance
Finance advance
Share premium
Premiums related to the share capital
Disclosure of events after reporting period [text block]
Subsequent events
Option exercisable, beginning balance
Number of share options exercisable in share-based payment arrangement
Option exercisable, ending balance
May Twelve Two Thousand and Twenty One
May Twelve Two Thousand and Twenty One [Member]
05/12/2021 [member]
Sensitivity of derivative fair value to expected life period
Sensitivity of derivative fair value to expected life period
Sensitivity of derivative fair value to expected life period.
The amount of provisions for employee litigation and severance reversal.
Provisions for employee litigation and severance reversal
Employee litigation and severance, Reversals
Disclosure of estimation of retirement indemnity to employee explanatory.
Disclosure of estimation of retirement indemnity to employee explanatory
Schedule of Estimation of Retirement Indemnity to Employee
Fixtures, fittings and other equipment.
Fixtures, Fittings and Other Equipment [Member]
Acquisition Related Right To Licence
Acquisition related right to licence.
Acquisition related right to licence
Collaboration Agreement Milestone Payments Plus Tiered Royalties
Collaboration agreement milestone payments plus tiered royalties.
Milestone payments for tiered royalties
Conditional advances.
Conditional Advances
Conditional advances
Number of share options outstanding in share-based payment arrangement
Option outstanding, ending balance
Option outstanding, beginning balance
Entity Address, City or Town
Number of shares with double voting rights
Number Of Shares With A Double Voting Right
Number of Shares with a Double Voting Right.
Expected volatility warrants.
Expected Volatility Warrants
Expected volatility
Increase (decrease) through net exchange differences, intangible assets and goodwill
Translation adjustments
Continuing operations, unless line item indicates otherwise [member]
Disclosure of Information concerning groups consolidated operartions explanatory.
Disclosure of Information concerning Groups Consolidated Operartions Explanatory
Information concerning the Group's Consolidated Operations
Current value added tax receivables
VAT receivables
Tax (other than income tax and value added tax) and social receivables current.
Tax and social receivables current
Tax and social receivables
Non-current assets
Non-current assets
Total non-current assets
Security Exchange Name
Decrease through derecognition of derivative.
Derecognition of Derivative
Derecognition of AZ SIA derivative
Derecognition of AZ derivative
Contact Personnel Name
Other current financial liabilities.
Other Current Financial Liabilities [Member]
Deferred Tax Liabilities Gross
Deferred tax liabilities gross.
Deferred tax liabilities
Intangible assets and goodwill
Total intangible assets and goodwill
Beginning balance
Ending balance
Decrease In Personnel Expenses
Decrease In Personnel Expenses
Decrease in personnel expenses
Disclosure of changes in accounting estimates [abstract]
Levels of fair value hierarchy [axis]
Addition for current provision.
Addition For Current Provision
Current provision additions
Cash in foreign currencies percentage
Cash in foreign currencies percentage.
Number of warrant granted
Number of options granted
Measurement [domain]
Number of Additional Shares Due to Change in Conversation Ratio, Exercisable Options
The number of additional potential shares due to change in conversation ratio of exercisable options in share-based payment arrangements.
Option exercisable, change in coversion ratios
Average life of options.
Average Life of Options
Average life of options
Principal.
Principal [Member]
Classes of commitments.
Classes of commitments [axis]
Disclosure of classes of share capital [line items]
Disclosure of classes of share capital [line items]
Cash and cash equivalents from discontinued operations
Cash and cash equivalents from discontinued operations.
Cash from discontinued operations
Later than one year and not later than three years [member]
1-3 years [member]
SIA cash proceeds
SIA cash proceeds.
Deferred tax liabilities
Non-current deferred tax liabilities
Deferred tax liabilities
Statement of changes in equity [abstract]
Annual Limit To Carryforwards Use Against Future Taxable Profit
Annual Limit to carryforwards use against future taxable profit.
Annual Limit to carryforwards use against future taxable profit
Net income (loss) for the period
Net income (loss)
Net Loss
Net income (loss)
Non Voting Rights Period
Non voting rights period.
Non voting rights period
Licence fee income
Licenses
Schedule Of Cash Flow Statement Of Discontinued Operations
Schedule Of Cash Flow Statement Of Discontinued Operations [Table]
Foreign exchange gain
Foreign exchange gains
Cash on hand
Cash and bank accounts
Document Period End Date
Document Period End Date
Other current assets
Other current assets
Total other current assets
Other current financial assets (deposits)
Debt securities [member]
Class B Preferered shares with no voting rights [Member]
Class B Preferered shares with no voting rights.
Class B Preferered shares with no voting rights [Member]
Associates [axis]
ICFR Auditor Attestation Flag
Categories of related parties [axis]
Categories of related parties [axis]
Finance income expense [abstract].
Finance income expense [abstract]
Disclosure of non-adjusting events after reporting period [table]
Disclosure of trade receivables [line items]
Disclosure of trade receivables.
08/07/2024 [member]
August Seven Thousand And Twenty Four [Member]
August seven thousand and twenty four.
Disclosure of detailed information about current financial assets and cash and cash equivalents explanatory.
Disclosure Of Detailed Information About Current Financial Assets And Cash And Cash Equivalents Explanatory [Text Block]
Summary of Current Financial Assets and Cash and Cash Equivalents
Significant unobservable input, Probability of transaction completion
Significant unobservable input, Probability of transaction completion
Probability of transaction completion
Disclosure of changes in accounting estimates [table]
Right-of-use assets
Ending balance
Beginning balance
Right-of-use assets
Right-of-use assets
Deferred revenue including upfront payment.
Deferred Revenue Including Upfront Payment
Deferred revenue including upfront payment
Commercial litigation.
Commercial litigation [member]
Commercial litigation [Member]
Increase decrease in interest expense on lease liabilities.
Increase Decrease in Interest Expense on Lease Liabilities
Decrease / Increase in interest expense on lease liabilities
Increase / (Decrease) in interest expense on lease liabilities
Type One November Nine Two Thousand Twenty [Member].
Type One November Nine Two Thousand Twenty [Member]
09/11/2020 [member]
Other income
Other income
Other income
External other income
Personnel expenses.
Personnel Expenses [member]
Personnel Expenses [Member]
Fair value
Financial assets, at fair value
Total current financial liabilities and lease debts.
Total Current Financial Liabilities And Lease Debts
Total current financial liabilities and current lease debts
Total current financial liabilities and current lease debts
Issued capital
Total issued capital
Share capital
Financial assets outside scope of IFRS 7, class [member]
Investee.
Investee [Domain]
Weighted average fair value at measurement date other equity instruments outstanding
The weighted average fair value at the measurement date of outstanding equity instruments other than share options. [Refer: Weighted average [member]].
Weighted average exercise price per share, beginning balance
Weighted average exercise price per share, beginning balance
Weighted average exercise price per share, ending balance
Income tax
Effective tax expense
Total tax expense (income)
Tax income (expense)
Effective tax benefit (expense)
Consolidated operations [line items].
Consolidated operations [line items]
Consolidated operations [line items]
BPI Refundable Advance Agreement.
BPI Refundable Advance Agreement [Member]
Property, plant and equipment, accumulated depreciation, amortisation and impairment
Property, plant and equipment, accumulated depreciation, amortisation and impairment
Accumulated depreciation and impairment at end of period
The decrease in liabilities arising from financing activities resulting from interest payments.
Decrease Through Financing Cash Flows (Interest Payment), Liabilities Arising from Financing Activities
Interest paid financial liabilities and lease debts
Disclosure of schedule of off-balance sheet commitments.
Disclosure of Schedule of Off-balance Sheet Commitments Explanatory
Schedule of Off-balance Sheet Commitments
Revenue [abstract]
Call Option July Eleventh Two Thousand And Twenty Five [Member]
Call option july eleventh two thousand and twenty five.
Call options
Foreign exchange rate
Foreign exchange rate [Member]
Foreign exchange rate.
May Fifteen Two Thousand And Twenty Four [Member]
May Fifteen Two Thousand And Twenty Four
05/15/2024 [member]
Contract liabilities
Contract liabilities at end of period
Contract liabilities at beginning of period
Deferred revenues
Total contract liabilities
Disclosure Of Number And Weighted Average Exercise Prices Of Share Options and awards [Line Items]
Disclosure Of Number And Weighted Average Exercise Prices Of Share Options and awards [Line Items]
Disclosure Of Number And Weighted Average Exercise Prices Of Share Options and awards [Line Items]
Financial liability maturity.
Financial Liability Maturity
Financial liability maturity
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Types of financial liabilities [axis]
Cibus global LLC.
Cibus Global LLC [Member]
Cibus Global [Member]
Disclosure of impairment loss and reversal of impairment loss [table]
Warrants.
Warrant1 [member]
Warrants [Member]
January Thirty Two Thousand Twenty Five [Member]
January thirty two thousand twenty five.
1/30/2025 [member]
Current financial liabilities
Current financial liabilities
Total current financial liabilities
Valuation techniques used in fair value measurement [domain]
Milestone received.
Milestone Received
Milestone received
Other current payables
Other
Reversal of current provisions.
Reversal Of Current Provisions
Current provisions Reversals
Other comprehensive income, before tax, exchange differences on translation
Currency translation adjustment
Other comprehensive income, before tax, exchange differences on translation of foreign operations
Classes of financial assets [domain]
Losses on change in fair value of derivatives
Losses on change in fair value of derivatives
Loss on fair value measurement
November Thirty Two Thousand and Twenty One
November Thirty Two Thousand and Twenty One [Member]
09/30/2021 [member]
Disclosure Of Maturities Of Financial Liabilities Explanatory [text block]
Disclosure of maturities of financial liabilities explanatory.
Remaining contractual maturities of financial liabilities
Expected dividend as percentage, share options granted
Expected dividends
All Currencies [Domain]
Decrease in net defined benefit liability in salary increase rate.
Decrease In Net Defined Benefit Liability In Salary Increase Rate
Decrease of net defined benefit liability
Increase in number of preferred shares.
Increase In Number Of Preferred Shares
Capital increase by issuance of preference shares
Decrease in financial income.
Decrease In Financial Income
Increase (decrease) through transfers, property, plant and equipment
Reclassification
Reclassification
Class Of Warrants Or Right [Domain]
Deferred tax assets and liabilities [abstract]
Change in Fair Value of Europen Investment Bank
Change in fair value of europen investment bank.
NEW YORK
New York [Member]
Cibus, Inc.
Cibus Inc [Member]
Profit (loss) from continuing operations
Income (loss) from continuing operations
Income (loss) from continuing operations
Net (loss) income for the period from continuing operations
Income tax effect on revenue
Income tax effect on revenue.
Tax effect on revenue recognized
Classes of other provisions [axis]
Discontinued Operations Consideration Received
Discontinued operations, consideration received.
Consideration received
Strengthening
Equity Net Of Tax Strengthening [Member]
Equity net of tax strengthening.
Categories of non-current financial assets [abstract]
Description of presentation currency explanatory.
Description Of Presentation Currency Explanatory
Currency of the financial statements
The amount of current grant receivables.
Current subsidies receivables
Subsidies receivables
Entity File Number
Fixed interest rate.
Fixed Interest Rate
Annual rate of discounting
Additional Research Plans under the AZ JRCA One.
Additional Research Plans under the AZ JRCA One [Member]
Additional Research Plans under the AZ JRCA One [Member]
Increased in base rent for setting the amount of deposit.
Increased In Base Rent For Setting The Amount Of Deposit
Increased in base rent for setting the amount of deposit
Call option May Thirteenth Two Thousand And Twenty Five [Member]
Call option may thirteenth two thousand and twenty five.
Call options
Weighted Average Fair Value At Measurement Date Other Equity Instrument Granted
Weighted average fair value at measurement date other equity instrument granted.
Weighted average exercise price per share, granted
Cover [Abstract]
Schedule of Share Warrants and Non-employee Warrants
Disclosure of potentially dilutive instruments explanatory
Disclosure of potentially dilutive instruments [text block]
Purchases and external expenses.
Purchases And External Expenses
Purchases and external expenses
Purchases and external expenses
Leased equipment.
Leased Equipment [Member]
Leased Equipment [Member]
Warrants issued.
Warrants Issued
Warrants Issued
Disclosure of deferred income and contract liabilities.
Disclosure of Deferred Income and Contract Liabilities Explanatory
Class of stock.
Class of shares [Axis]
Investee.
Investee [Axis]
Disclosure of quantitative information about right-of-use assets [line items]
Percentage of increase in salary increase rate.
Percentage Of Increase In Salary Increase Rate
Percentage of increase in salary increase rate
March Three Thousand Twenty Two [Member]
March Three Thousand Twenty Two [Member]
03/03/2022 [member]
Decrease In Employee Benefits Expense
Decrease In Employee Benefits Expense
Decrease in stock-based compensation expense
Non-current Lease Liabilities
Non-current Lease Liabilities [Member]
Non Current Lease Debts [Member]
Agreements Extended Maturity Date
Agreements Extended Maturity Date
Agreements extended maturity date
Non-current fixed term bank deposits including accrued interests.
Non-current Fixed term Bank Deposits including Accrued Interests
Non-current fixed term bank deposits including accrued interests
Us Dollar [Member]
Us Dollar [member]
US Dollar
Fair value of expected volatility percentage
Fair Value Of Expected Volatility Percentage
Fair value of expected volatility percentage.
Level 1 of fair value hierarchy [member]
Level 1 [member]
Significant unobservable input, assets
Rate at maturity
Disclosure of related party [text block]
Related parties and other major shareholders
Current liabilities [abstract]
Current liabilities
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
November Seven Two Thousand Twenty Five [Member]
November seven two thousand twenty five.
11/7/2025 [member]
Categories of financial liabilities [axis]
March fourteen two thousand sixteen.
March fourteen two thousand sixteen [member]
3/14/2016 [member]
Cellectis SA.
Cellectis SA [Member]
Description of vesting requirements for share-based payment arrangement
Vesting conditions
Vesting period
Disclosure of financial assets [abstract]
Disclosure of financial assets [abstract]
The description of inputs used in the fair value measurement of liabilities. Inputs are the assumptions that market participants would use when pricing the liability, including assumptions about risk such as the risk inherent in a particular valuation technique used to measure fair value (such as a pricing model) and the risk inherent in the inputs to the valuation technique.
Description of inputs used in fair value measurement, liabilities [Table text block]
Disclosure of assumptions and results of the warrant valuation
January Twenty Four Two Thousand And Twenty Three [Member]
January twenty four two thousand and twenty three.
01/24/2023 [member]
Increase (decrease) in wages and salaries.
Increase (Decrease) in Wages and Salaries
Increase (decrease) in wages and salaries
Trade payables.
Trade Payables [member]
Trade Payables [member]
Put Options May Fifteenth And Twenty Twenty Six [Member]
Put options may fifteenth and twenty twenty six.
Put options
Disclosure of number and weighted average exercise prices of share options [text block]
Summary of Information on Stock Option Activity
Profit And Loss Strengthening [Member]
Profit and loss strengthening.
Strengthening
Text Block [Abstract]
Text block1 [abstract]
Text block1 [abstract]
Disclosure of current financial assets and cash and cash equivalents explanatory.
Disclosure of current financial assets and cash and cash equivalents explanatory [Text Block]
Current financial assets and Cash and cash equivalents
Disclosure of earnings per share [text block]
Earnings per share
IT Licensing agreement.
IT Licensing agreement [member]
IT Licensing Agreements [Member]
Non-current fixed term bank deposits maturity date
Non-Current Fixed Term Bank Deposits Maturity Date
Non-current fixed term bank deposits maturity date
Other provision for charges additions.
Other Provision For Charges Additions
Other provision for charges, Additions
Liability asset of defined benefit plans reclassification.
Liability Asset Of Defined Benefit Plans reclassification
Reclassification/CTA
Description of method of settlement for share-based payment arrangement
Type
Number of shares outstanding
Balance at end, Number of shares
Balance at beginning, Number of shares
Number of shares ordinary outstanding
Ownership [Axis]
Subsidies receivables.
Subsidies receivables [member]
Subsidies Receivables [member]
Option outstanding, additional shares due to May 2024 modification
Number Of Share Options Additional Shares Due To May Twenty Twenty Four Share Based Payment Arrangement
Number of share options additional shares due to May Twenty Twenty Four share based payment arrangement.
Disclosure of terms and conditions of share-based payment arrangement [line items]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Assumptions and results of the warrants valuation
Other current financial liabilities
Other current liabilities
Other current liabilities
Current investments
Current investments
Current investment
Provision for tax litigation used during the period.
Provision for Tax Litigation Used During The Period
Provision for tax litigation, Amounts used during the period
Financial liabilities at amortised cost, category [member]
Financial Liabilities at Amortised Cost, Category [Member]
Disclosure of other current assets [text block]
Disclosure of Other Current Assets
Increase (decrease) through net exchange differences, property, plant and equipment
Translation adjustments
Financial assets at fair value through profit or loss, category [member]
Financial Assets at Fair Value Through Profit or Loss, Category [Member]
Disclosure of other receivables, prepayments and other current asset.
Disclosure of Other Receivables Prepayments and Other Current Assets [Abstract]
Disclosure of detailed information about provisions.
Disclosure Of Detailed Information About Provisions [Text Block]
Details of Provisions
Proportion of ownership interests held by non-controlling interests
Non-controlling shareholders interest
Capital requirements [domain]
Option Life Share Option Granted
The option life of share option granted.
Option life, share option granted
Fair value probability of transaction completion plus two percent
Fair value probability of transaction completion plus two percent
Probability of transaction completion +2%
Other provision for charges reversals.
Other Provision For Charges Reversals
Other provision for charges, Reversals
Cybersecurity Risk Management Processes Integrated [Flag]
Increase (Decrease) In Research Tax Credit
Increase Decrease In Research Tax Credit
Decrease In Research Tax Credit
Increase (decrease) in research tax credit
Risk free interest rate, share options granted
Risk-free interest rate
Document Transition Report
Increase In Number Of Ordinary Shares Issued Due To Vesting Of Free Shares And Stock Option Exercises
The increase in the number of ordinary shares issued due to vesting of free shares and exercise of stock options granted to employees and directors in share-based payment arrangements.
Exercise of share warrants, employee warrants, stock-options and free-shares vesting, shares
Percentage of Taxable Income Subject to Annual Limitation
Percentage of taxable income subject to annual limitation.
Percentage of taxable income subject to annual limitation
Total non-current financial liabilities and non-current lease debts.
Total Non current Financial Liabilities And Non current Lease Debts
Total non-current financial liabilities and non-current lease debts
Non-current financial liabilities and non-current lease debts, Ending balance
Non-current financial liabilities and non-current lease debts, Beginning balance
Total non-current financial liabilities and non-current lease debts
Profit or loss [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Statement of financial position [abstract]
Royalty expenses
Royalty expense
Prepaid expenses and other current assets.
Prepaid Expenses and Other Current Assets [Line Items]
Prepaid expenses and other current assets [line items]
Additions
Additions deletions other than through business combinations intangible assets other than goodwill.
Additions Deletions Other Than Through Business Combinations Intangible Assets Other Than Goodwill
Additions to intangible assets
No Trading Symbol Flag
Selling general and administrative expenses
Selling General And Administrative Expenses 1 [Member]
Selling, General and Administrative Expenses [Member]
Current assets [abstract]
Current assets
Other comprehensive income
Total other comprehensive income (loss)
Other comprehensive income (loss)
Approval of research plan developement milestone payment.
Approval of research plan developement milestone payment
Proportion of ownership interest in associate
Ownership interest in associate
Percentage of share capital
May Twenty Eight Two Thousand and Twenty One
May Twenty Eight Two Thousand and Twenty One [Member]
05/28/2021 [member]
Classes of assets [domain]
Retirement indemnities.
Retirement Indemnities [Member]
Retirement Indemnities [Member]
Weighted average exercise price of share options granted in share-based payment arrangement
Weighted average exercise price per share, granted
Fair value expected life of derivative estimated by management
Fair value expected life of derivative estimated by management.
Expected life of derivative estimated by management
Net cash flows provided by (used in) operating activities of continuing operations
Cash flows from (used in) operating activities, continuing operations
Net cash flows from (used in) operating activities, continuing operations
Current provisions other comprehensive income.
Current Provisions Other Comprehensive Income
Current provisions OCI
Components of equity [axis]
Components of equity [axis]
Types of antidilutive instruments [axis]
Increase in research and development expense
Increase in Research and Development Expense
Increase in research and development expense.
Selling, general and administrative expense [member]
Selling General and Administrative Expense [Member]
Adjustments for gain (loss) on disposals, property, plant and equipment
Net loss (income) on disposals
Cash flows from (used in) operations before changes in working capital
Operating cash flows before change in working capital
Basic earnings (loss) per share
Basic net income (loss) attributable to shareholders of Cellectis per share ( $ /share)
Total basic earnings (loss) per share
Basic net income (loss) attributable to shareholders of Cellectis, per share ($ /share)
Cybersecurity Risk Management Processes Integrated [Text Block]
Increase In Depreciation And Amortization Expenses
Increase In Depreciation And Amortization Expenses
Increase in depreciation and amortization expenses
At fair value [member]
Fair Value [Member]
Provisions for retirement indemnities.
Provisions For Retirement Indemnities
Retirement indemnities , Ending Balance
Retirement indemnities , Beginning Balance
Legal and Finance External Support [Member]
Legal and Finance External Support.
Fair Value Of Shares In Amount
Fair value of shares in amount.
Fair value of shares
Number of derivative instruments warrant granted.
Number of Derivative Instruments Warrant Granted
Number of options granted
Office and Laboratory equipment [member]
Office and Laboratory equipment.
Office and laboratory equipment [Member]
Reallocated proceeds from sale of ordinary shares.
Reallocated Proceeds From Sale Of Ordinary Shares
Reallocated proceeds from sale of ordinary shares
Adjustments for realized foreign exchange losses gains.
Adjustments For Realized Foreign Exchange Losses Gains
Realized foreign exchange gain (loss)
Percentage of derivative fair value probability of transaction completion
Percentage of derivative fair value probability of transaction completion
Percentage of derivative fair value probability of transaction completion.
Purchase of intangible assets, classified as investing activities
Acquisition of intangible assets
Purchase of intangible assets
Number of warrants issued.
Number Of Warrants Issued
Number of warrants issued
Adjustments for depreciation and amortisation expense
Amortization and depreciation
Adjustments for depreciation and amortisation expense, Total
Attribution of expenses by nature to their function [axis]
Provisions
Ending balance
Beginning balance
Total provisions
Gain in Financial Expenses
Gain in financial expenses.
Gain in financial expenses
Current trade receivables
Trade receivables
Total net value of trade receivables
Total net value of trade receivables
Call Options May Twenty Six And Twenty Twenty Six [Member]
Call options may twenty six and twenty twenty six .
Call options
Initial fair value amount.
Initial Fair Value Amount
Initial fair value amount
Maturity [domain]
Liabilities arising from financing activities
Financial liabilities and lease debts, Ending balance
Financial liabilities and lease debts, Beginning balance
Share price used as input to the option pricing model to calculate the fair value of share options granted.
Underlying Stock Price at Grant Date
Underlying stock price at grant date
Cash flows from (used in) financing activities, discontinued operations
Net cash flows provided by (used in) financing activities of discontinued operations
Net cash flows provided by (used in) financing activities of discontinued operations
Net cash flows from (used in) financing activities, discontinued operations
Leased premises.
Leased Premises [Member]
Leased Premises [Member]
Document Fiscal Year Focus
Document Fiscal Year Focus
Fair value expected probability of transaction completion estimated by management
Fair value expected probability of transaction completion estimated by management.
Expected probability of transaction completion estimated by management
Increase In Purchases And External Expenses
Increase In Purchases And External Expenses
Increase in purchases and external expenses
Investments accounted for using equity method
Total investments accounted for using equity method
Equity investment
Ordinary shares [member]
Share Capital Ordinary Shares [member]
Common Stock [Member]
Maturity [axis]
Maturity [axis]
Expiration Date.
Expiration Date
Expiration date
Current Lease Liabilities
Current Lease Liabilities [Member]
Current Lease Debts [Member]
Spot Share Price Per Share
Spot share price per share.
Spot share price
Weighted average number of ordinary shares outstanding
Weighted average number of outstanding shares, used to calculate basic net result per share
Basic
Disclosure of detailed information about deferred income and contract liabilities.
Disclosure Of Detailed Information About Deferred Income And Contract Liabilities Explanatory
Details of Deferred Income and Contract Liabilities
Cash cash and cash equivalents and current assets.
Cash Cash and Cash equivalents and current assets [Member]
Cash Cash and Cash Equivalents and Current Assets [member]
Increase in share capital of Cellectis after deduction of transaction costs
Proceeds From Issuing Shares, Net Of Issuance Cost
Proceeds from issuing shares, net of issuance cost.
Increase in share capital from financing activities
Geographical areas [domain]
Disclosure of contingent liabilities [table]
Gains (Losses) On Change In Fair Value Of Investments
Gains (losses) on change in fair value of investments.
Gain (loss) on change in fair value of our investment
Financial liabilities, excluding EIB warrants.
Financial Liabilities, Excluding EIB Warrants
Financial liabilities, excluding EIB warrants
Increase (decrease) in cash and cash equivalents
(Decrease) increase in cash and cash equivalents
(Decrease) increase in cash and cash equivalents
Net increase (decrease) in cash and cash equivalents after effect of exchange rate changes
Cash and cash equivalents
Decrease in financial investments gain.
Decrease in financial investments gain
Disclosure of expenses by nature [text block]
Details of Operating Expenses by Nature
Proceeds from disposal of non-current assets or disposal groups classified as held for sale and discontinued operations
Consideration received in cash
Convertible note nominal amount.
Convertible Note Nominal Amount
Convertible note nominal amount
Disclosure of current financial assets and cash and cash equivalents.
Disclosure of Current Financial Assets and Cash and Cash Equivalents [Table]
Disclosure of Current Financial Assets and Cash and Cash Equivalents [Table]
Level 3 of fair value hierarchy [member]
Level 3 [member]
Gains (losses) on change in fair value of derivatives
Net gains (losses) on change in fair value of derivatives
Loss on fair value measurement
Non-current finance lease receivables
Finance lease receivable
Non-current liabilities [abstract]
Non-current liabilities
Attributable Profit Loss From Deconsolidation
Attributable profit loss from deconsolidation.
Profit from deconsolidation
Subsidiaries [axis]
Subsidiaries [axis]
Foreign exchange differences
Increase (decrease) in net defined benefit liability (asset) resulting from changes in foreign exchange rates, net defined benefit liability (asset)
Estimation of retirement indemnity to employee social security contributions percentage.
Estimation of retirement indemnity to employee social security contributions percentage
% social security contributions
Classes of liabilities [domain]
Non current lease debts [Member]
Non current lease debts [Member]
Non Current Lease Debts [member]
Gross carrying amount [member]
Gross value [member]
Gross Value [Member]
Financial assets at amortised cost, category [member]
Financial Assets at Amortised Cost, Category [Member]
Number of other equity instruments exercised or vested in share-based payment arrangement
Number of free shares vested
Voting agreement with cibus.
Voting Agreement with Cibus [Member]
Voting Agreement with Cibus [Member]
Reinvoicing to AZ Ireland of research costs rechargeable.
Reinvoicing to AZ Ireland of Research Costs Rechargeable [Member]
Reinvoicing to AZ Ireland of Research Costs Rechargeable [Member]
Subsequent investment agreement.
Subsequent Investment Agreement [Member]
Subsequent Investment Agreement (SIA) [Member]
Discolsure of Detailed Information About Share based Payment Arrangements [Text Block]
Disclosure of detailed information about share based payment arrangements [Text Block]
Summary of assumptions Vesting Details
Average effective tax rate
Effective tax rate
Effective income tax rate
Effective tax rate
Weighted average exercise price of share options exercised in share-based payment arrangement
Weighted average exercise price per share, exercised
Weighted average exercise price per share, exercised/vested
Interest rate, measurement input [member]
Interest Rate, Measurement Input [Member]
Share price of warrant.
Share Price Of Warrant
Share price (in euros)
Share price
Other adjustments for non-cash items
Other non-cash items
Other non-cash transactions
Cash flows from (used in) operating activities, discontinued operations
Net cash flows provided by (used in) operating activities of discontinued operations
Net cash flows from (used in) operating activities, discontinued operations
Categories of financial assets [axis]
Disclosure of number and weighted average grant date fair value of other equity Instruments Explanatory
The disclosure of the number and weighted average grant date fair value of other equity instruments (i.e. other than share options) in share-based payment arrangements.
Disclosure of subsidiaries [table]
Capital evolution 2023.
Capital Evolution 2023 [Member]
Capital Evolution 2023 [Member]
Fixed term bank deposit including accrued interest.
Fixed Term Bank Deposit Including Accrued Interest
Fixed term bank deposit including accrued interest
Disclosure of fair value of financial instruments [text block]
Summary of Financial Assets and Liabilities
Number of share options forfeited in share-based payment arrangement
Option outstanding, forfeited, cancelled or expired
Provision for tax litigation, Reversals
Provision For Tax Litigation Reversals
Provision for tax litigation, Reversals
Property, plant and equipment by operating lease status [domain]
Liabilities [abstract]
LIABILITIES
Cash flows from (used in) financing activities [abstract]
Cash flows from financing activities
Schedule Of Cash Flow Statement Of Discontinued Operations
Schedule Of Cash Flow Statement Of Discontinued Operations [Line Items]
Class A convertible preferred shares.
Class A convertible preferred shares [Member]
"Class A" Convertible Preferred Shares [Member]
Class A" Convertible Preferred Shares [Member]
Preference shares [member]
Preferrence Shares [Member]
Disclosure of intangible assets [text block]
Intangible assets
Range [domain]
Derivative Instruments Exercise Price
Derivative instruments exercise price.
Summary of Property Plant and Equipment Estimated Useful Lives
Disclosure of Property, Plant and Equipment Estimated Useful Lives [Text Block]
Disclosure of property, plant and equipment estimated useful lives.
Financial derivative derecognized.
Financial Derivative Derecognized
Financial derivative derecognized
Statement of changes in equity [line items]
Property, plant and equipment
Ending balance
Beginning balance
Property, plant and equipment
Total property, plant and equipment
Title of 12(b) Security
Carrying value.
Carrying Amount and value [Member]
Carrying Value [member]
Primera therapeutics, Inc.
Primera Therapeutics Inc [Member]
Primera Therapeutics, Inc. [Member]
Number of share options granted in share-based payment arrangement
Number of equity instruments granted in share-based payment arrangement
Option outstanding, granted
Research tax credit non-current financial assets.
Research Tax Credit Non-current Financial Assets
Research tax credit
Research tax credit receivables
Retained earnings, excluding profit (loss) for reporting period
Retained earnings (deficit)
The entire disclosure in details of financial liabilities and lease debts.
Disclosure of Detailed Financial Liabilities and Lease Debts Explanatory
Financial liabilities and lease debts
Trade receivables [member]
Trade Receivables [member]
Weighted average exercise price of share options exercisable granted in share based payment arrangements.
Weighted Average Exercise Price Of Share Options Exercisable Granted In Share Based Payment Arrangements
Weighted- average exercise price per share, granted
Other provision for charges.
Other Provision For Charges
Other provision for charges, Ending balance
Other provision for charges, Beginning balance
Other provision for charges, Biginning balance
Secured bank loans received
Loan received from bank
Classes of other provisions [domain]
Increase (decrease) in financial assets
Total increase (decrease) in financial assets
Current financial assets
Document Information [Table]
Legal Entity [Axis]
Legal Entity [Axis]
Deferred Tax Assets From Other Deductible Differences
Deferred tax assets from other deductible differences.
Deferred tax assets from other deductible differences
Disclosure of other provisions [line items]
Provision for tax litigation other comprehensive income.
Provision For Tax Litigation Other Comprehensive Income
Provision for tax litigation, OCI
State and local tax authority.
State And Local Tax Authority [Member]
Increase in number of ordinary shares issued
Increase in number of ordinary shares issued.
Capital increase, Shares
Disclosure of detailed information about property, plant and equipment [abstract]
Calyxt.
Calyxt [Member]
Calyxt [member]
Disclosure of contingent liabilities [line items]
Total Current Financial Liabilities and Current Lease Debts
Total Current Financial Liabilities and Current Lease Debts [Member]
Current provisions
Current provisions Ending balance
Current provisions beginning balance
Current provisions
Total current provisions
Property, plant and equipment by operating lease status [axis]
Property, plant and equipment by operating lease status [axis]
Free shares.
Free Shares [member]
Free Shares [member]
Social Security Contributions Including Prior Period Adjustments
Social Security Contributions Including Prior Period Adjustments
Social charges on stock option grants
Social charges on stock option grants
Disclosure of expected impact of initial application of new standards or interpretations [table]
Disclosure of changes in accounting estimates [table]
Deferred Tax Assets Capitalization Of Research And Development Expenses
Deferred tax assets capitalization of research and development expenses.
Capitalization of R&D expenses under SEC 174 rule
Profit (loss), attributable to non-controlling interests
Attributable to non-controlling interests
Net income (loss) attributable to NCI
Milestone [Axis]
Milestone [axis]
Disclosure of detailed information about financial instruments [abstract]
Disclosure of reconciliation of liabilities arising from financing activities [text block]
Disclosure of reconciliation of movements of liabilities to cash flows arising from financing liabilities
Trading Symbol
Purchase of financial assets measured at amortised cost, classified as investing activities
Acquisition of current financial assets
Non Executive Employees.
Non Executive Employees [Member]
Non-current derivative instruments.
Non-current derivative instruments [member]
Non-current Derivative Instruments (EIB warrants) [member]
Issuance Price Per Share
Issuance price per share.
Issuance price per share
Current provisions used during the period.
Current Provisions Used During the Period
Current provisions Amounts used during the period
Class B Preferred Shares
Class B Preferred Shares [Member]
Class B Preferred Shares.
Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract]
Number of shares used for computing
Sublease Start Term
Sublease start term.
Sublease start term
Buildings [member]
Building lease [member]
Federal R&D tax credits, tax loss carryforwards
Research and Development Tax Credits, Tax Effect of Tax Losses
Research and development tax credits, tax effect of tax losses.
Depreciation, right-of-use assets
Depreciation, right-of-use assets
Depreciation & impairment expense
Schedule Of Derivative Instruments Put And Call Options [Table Text Blpck]
Schedule of derivative instruments put and call options.
Schedule of derivative instruments put and call options
Disclosure of financial liabilities and lease debts.
Disclosure of financial liabilities and lease debts explanatory [text block]
Detail of financial liabilities and lease debts
Schedule Of Income Statement Of Discontinued Operations
Schedule Of Income Statement Of Discontinued Operations [Table]
Increase (decrease) through changes in fair values, liabilities arising from financing activities
Non-cash change in fair value financial liabilities and lease debts
Class B convertible preferred shares.
Class B convertible preferred shares [Member]
Class B" Convertible Preferred Shares [Member]
Equity investment.
Equity investment
Equity investment
Tranche B Warrants [Member]
Tranche B Warrants [Member]
Defined benefit plans [axis]
Defined benefit plans [axis]
Risk Free Rate [Member]
Risk Free Rate.
Risk-Free Rate
Federal tax authority.
Federal Tax Authority [Member]
Disclosure of classes of share capital [table]
Disclosure of classes of share capital [table]
Laboratory equipment.
Laboratory Equipment [Member]
Laboratory Equipment [member]
Deferred Tax Assets Leases Liabilities
Deferred tax assets leases liabilities.
Leases liabilities
Number of other equity instruments exercisable in share-based payment arrangement
Number of exercisable warrants and stock options as of 12/31/2025
Research Tax Credits Financing Arrangement
Research tax credits financing arrangement.
Increase Decrease In Foreign Exchange Losses.
Increase Decrease In Foreign Exchange Losses
Increase/ Decrease in foreign exchange losses
September eight two thousand fifteen.
September eight two thousand fifteen [member]
9/8/2015 [member]
Effective interest rate of loan.
Effective Interest Rate of Loan
Effective interest rate of loan
Weighted average exercise price of other equity instruments exercisable in share-based payment arrangement
Exercise price per option / warrant in Euros
Non-current derivative financial liabilities
Non-current derivative financial liabilities
Key management personnel compensation, short-term employee benefits
The increase in the number of ordinary shares issued due to vesting of free shares granted to employees and directors in share-based payment arrangements.
Increase In Number Of Ordinary Shares Issued Due To Vesting Of Free Shares
Vesting of free shares granted to employees and directors, shares
Shares issued to the benefit of employees related free share plans
Cellectis, Inc. and Cellectis Biologics, Inc. [Member]
Cellectis, inc. and cellectis biologics, inc.
Address Type [Domain]
The increase (decrease) in liabilities arising from financing activities resulting from reclassifications between current and non-current activities.
Increase (Decrease) Through Reclassification Between Current and Non-Current, Liabilities Arising from Financing Activities
Reclassifications financial liabilities and lease debts
Restricted share units [member]
Restricted Stock Unit Awards [member]
Licence Of Patents [Member]
Licence of patents.
License of Patents [Member]
Document Annual Report
Increase (decrease) in purchases, external expenses and other.
Increase (Decrease) in Purchases, External Expenses and Other
Increase (decrease) in purchases, external expenses and other
Decrease in purchases, external expenses and other
Income Tax Authorities [Axis]
Income Tax Authorities [Axis]
Current accrued liabilities for personnel related expenses.
Current accrued liabilities for personnel related expenses
Accruals for personnel related expenses
Trade payables
Trade payables
Trade payables
Equity [abstract]
Shareholders' equity
Provision Used Including Provision for Employee Benefits
Provision used including provision for employee benefits.
Amounts used during the period
Borrowings by name [axis]
Percentage of probability of transaction completion.
Percentage of Probability of Transaction Completion
Percentage of probability of transaction completion
Classes of intangible assets other than goodwill [axis]
Exercise of share warrants and employee warrants amount.
Exercise of share warrants and employee warrants amount
Exercise of share warrants, employee warrants, stock-options and free-shares, amount
Exercise of share warrants, employee warrants, stock-options and free-shares vesting
Construction in progress [member]
Assets Under Construction [Member]
The increase (decrease) in liabilities arising from financing activities resulting from other non-cash changes.
Increase (Decrease) Through Other Non-Cash Movements, Liabilities Arising from Financing Activities
Other non-cash movements financial liabilities and lease debts
Fair Value Of Derivative
Fair value of derivative.
Fair value measurement of derivative
Disclosure of financial liabilities [abstract]
Disclosure of detailed information about intangible assets [table]
Expected volatility plus five percent.
Expected Volatility Plus Five Percent [Member]
Expected volatility +5% [Member]
Document Accounting Standard
Revenue that was included in contract liability balance at beginning of period
Revenue that was included in contract liability balance at beginning of period
Disclosure of commitments [text block]
Commitments
Off-balance sheet commitments
Assets
Assets at end of period
Assets at beginning of period
TOTAL ASSETS
Prepaid Expenses and Other Current Assets [Table]
Prepaid Expenses and Other Current Assets [Table]
Prepaid Expenses and Other Current Assets [Table]
Reversal of non current provisions.
Reversal Of Non Current Provisions
Non current provisions Reversals
Entity Addresses, Address Type [Axis]
Cash and cash equivalents [abstract]
The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed.
Risk Free Interest Rate Warrants
Risk free rate
Tax effect of tax losses
Credits and net operating loss carryforwards
Disclosure of detailed information about other current liabilities.
Disclosure of detailed information about other current liabilities [Text Block]
Summary of Other Current Liabilities
Description of accounting policy for going concern explanatory.
Description Of Accounting Policy For Going Concern Explanatory
Going concern
Number of other equity instruments outstanding in share-based payment arrangement
Number of outstanding instruments as of 12/31/2025
Number of outstanding instruments as of 01/01/2025
Unused provisions reversed including employee benefits.
Unused Provisions Reversed Including Employee Benefits
Pension, Reversals
Adjustments for increase (decrease) in trade account payable and other current liabilities.
Adjustments For Increase (Decrease) In Trade Account Payable And other current liabilities
(Decrease) increase in trade payables and other current liabilities
Change in provisions through other comprehensive income including provisions for employee benefits.
Change in Provisions through Other Comprehensive Income Including Provisions for Employee Benefits
OCI
Disclosure of other provisions [table]
Performance Stock Unit.
Performance Stock Unit [Member]
Performance Stock Unit [Member]
Components of equity [domain]
Types of share-based payment arrangements [axis]
Types of share-based payment arrangements [axis]
Loss in fair value measurement
Loss in fair value measurement.
Other subsidies receivables.
Other Subsidies Receivables
Other subsidies
Increase (decrease) through net exchange differences, right-of-use assets
Translation adjustments
Par value per share
Nominal value
Par value per share
Subscription/ Spot share price
European Investment Bank Loan
European Investment Bank Loan [Member]
European Investment Bank Loan [Member]
European Investment Bank Credit Facility [Member]
Other operating income (expense)
Other operating income (expenses)
Other operating income and (expense)
Weighted average exercise price per share, ending balance
Weighted average exercise price per share, beginning balance
Weighted average exercise price per share, cancelled, forfeited or expired
Disclosure of cash and cash equivalents [text block]
Details of Cash and Cash Equivalents
Gain in fair value measurement
Gain in fair value measurement
Minimum revenue to be achieved.
Minimum revenue to be achieved
Preferred Shares Conversion Ratio
Preferred shares, conversion ratio.
Conversion ratio
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Pension commitments
Deferred tax assets pension commitments.
Deferred tax assets pension commitments
Pension commitments
Other comprehensive income, before tax, exchange differences on translation, other than translation of foreign operations
Currency translation adjustment generated by the parent company
Equity awards.
Equity awards [member]
Equity awards [member]
Disclosure of quantitative information about right-of-use assets [table]
Weighted average number of ordinary shares used in calculating diluted earnings per share
Diluted
Weighted average number of outstanding shares, net of effects of dilutive potential ordinary shares
Disclosure of revenue.
Disclosure of Revenue [Table]
Disclosure of Revenue [Table]
Grant Refundable Advance Received
Grant refundable advance received.
Grand refundable advance received
Average Life Options
Average life options.
Average life of options
Deferred income other than contract liabilities
Other deferred income
June Twenty Three Two Thousand Twenty Five [Member]
June twenty three two thousand twenty five.
6/23/2025 [member]
Non-current assets [abstract]
Non-current assets
Milestone Payment For 10 Candidate
Milestone payment for 10 candidate.
Milestone Payment For 10 Candidate
Current trade payables
Trade payables
Disclosure of finance income (cost) [text block]
Details of Financial Income and Expenses
Expected life of derivative
Expected life of derivative
Expected life of derivative
Disclosure of discontinued operations [text block]
Discontinued operations
Commercial litigation other comprehensive income.
Commercial Litigation Other Comprehensive Income
Commercial litigation, OCI
Diluted earnings (loss) per share
Diluted net income (loss) attributable to shareholders of Cellectis per share ( $ /share)
Total diluted earnings (loss) per share
Diluted net income (loss) attributable to shareholders of Cellectis, per share ($ /share)
Disclosure of reconciliation of liabilities arising from financing activities [table]
Cytovia.
Cytovia [Member]
FRANCE
France [Member]
FRANCE
Weighted Average Fair Value At Measurement Date Other Equity Instrument Vested
The weighted average fair value at the measurement date of other equity instruments (ie other than share options) vested in a share-based payment arrangement. [Refer: Weighted average [member]".
Weighted average exercise price per share, Vested
Discount rate
Discount rate
Discount rate
Entity Registrant Name
Entity Registrant Name
Disclosure of defined benefit plans [abstract]
Entity Voluntary Filers
Financial assets at amortised cost
Accounting category amortized cost
Non-current portion of non-current loans received
Non current liability of loan
Conditional advances
Statement of changes in equity [table]
Intangible assets and goodwill accumulated depreciation and impairment.
Intangible assets and goodwill accumulated depreciation and impairment
Accumulated depreciation and impairment at end of period
Increase (decrease) cash, cash equivent and current financial assets
Increase (decrease) cash, cash equivent and current financial assets.
Total cash, cash equivent and current financial assets
Disclosure of trade receivables [table]
Disclosure of trade receivables.
Cybersecurity Risk Management Positions or Committees Responsible [Flag]
Disclosure of financial assets [line items]
Country Region
Provisions for retirement indemnities reversals.
Provisions For Retirement Indemnities Reversals
Retirement Indemnities , Reversals
Class Of Shares.
Class Of Shares [Domain]
Valuation techniques used in fair value measurement [axis]
Increase (decrease) in contract liabilities.
Increase (Decrease) in Contract Liabilities
Increase in deferred revenue
Gauranteed borrowing amount percentage.
Gauranteed Borrowing Amount Percentage
Guaranteed borrowing amount, percentage
Short-term deposits, classified as cash equivalents
Cash and bank accounts
Fixed bank deposits
Agreement extended period [member]
Agreement extended period.
Agreement Extended Period [Member]
Description of accounting policy for transactions with AstraZenea explanatory.
Description Of Accounting Policy For Transactions With AstraZenea Explanatory
Accounting treatment of transactions with AstraZeneca
Statement of comprehensive income [abstract]
Disposals and retirements, property, plant and equipment
Disposal
Total disposals and retirements, property, plant and equipment
Depreciation And Amortization Expenses Inclusive Right Of Use Amortization
Depreciation And Amortization Expenses Inclusive Right Of Use Amortization
Depreciation and amortization expenses (incl. right of use amortization)
Entity Common Stock, Shares Outstanding
It licensing agreements member.
It Licensing Agreements [Member]
IT Licensing Agreements [Member]
Share premium [member]
Premiums Related to Share Capital [member]
Equity
Balance at end of year
Beginning balance
Total shareholders' equity
Number of Potential Ordinary Shares Issued In Share Based Payment Arrangement
Number of potential ordinary shares issued in share based payment arrangement.
Maximum of shares to be issued
European Investment Bank Loan Tranche C.
European Investment Bank Loan - Tranche C [Member]
Classes of property, plant and equipment [domain]
Total Non-Current Financial Liabilities and Non-Current Lease Debts
Total Non-Current Financial Liabilities and Non-Current Lease Debts [Member]
Disclosure of net defined benefit liability (asset) [text block]
Summary of Net Defined Benefit Liability and Components
Disclosure of government grants [text block]
Disclosure of Subsidies Receivables
Decrease (increase) in financial income.
Increase Decrease In Financial Income
Decrease /increase in financial income
Non-current financial assets.
Non-current financial assets [member]
Non-current Financial Assets [member]
Remaining contractual life of option
Remaining Contractual Life Of Option
Contractual life of options
Fair value probability of transaction completion less two percent
Fair Value Probability of transaction completion less two percent.
Probability of transaction completion -2%
Follow on Offering Member
Follow on offering.
Proceeds from borrowings, classified as financing activities
Increase in borrowings
Secured Borrowings
The amount of revenue from products and services.
Revenue From Products Services
Products & services
Miscellaneous current liabilities [abstract]
Percentage of voting equity interests acquired
Percentage of voting rights
Voting rights
Share-based compensation expense
Expense from share-based payment transactions
Total expense from share-based payment transactions
Non-current provisions
Non current provisions Ending balance
Non current provisions beginning balance
Non-current provisions
Total non-current provisions
Percentage of increase in discount rate.
Percentage Of Increase In Discount Rate
Percentage of increase in discount rate
Decrease (increase) in financial Expenses.
Increase Decrease In Financial Expenses
Decrease /increase in financial Expenses
Other finance cost
Other financial expenses
Accumulated impairment [member]
Number of cash generating unit
Number of cash generating unit
Number of cash generating unit
Schedule Of Income Statement Of Discontinued Operations
Schedule Of Income Statement Of Discontinued Operations [Table Text Block]
Schedule Of Income Statement Of Discontinued Operations
Computer equipment [member]
IT Equipment [Member]
Other finance income
Number of candidate products for novel cell and gene therapy.
Number Of Candidate Products For Novel Cell And Gene Therapy
Number of candidate products for novel cell and gene therapy
Additional Research Plans under the AZ JRCA Two.
Additional Research Plans under the AZ JRCA Two [Member]
Additional Research Plans under the AZ JRCA Two [Member]
Prior service costs amendment [member]
Prior service costs amendment.
Disclosure of detailed information about property, plant and equipment [table]
Disclosure of detailed information about property, plant and equipment [table]
Details of Property, Plant and Equipment
January Twenty Five Thousand And Twenty Four [Member]
January twenty five thousand and twenty four.
01/25/2024 [member]
City Area Code
Additional Provisions including Provisions for Employee Benefits
Additional provisions including provisions for employee benefits.
Additions
Accumulated depreciation, amortisation and impairment [member]
Accumulated depreciation and impairment [member]
Accumulated Depreciation and Impairment [Member]
American depository shares.
American Depository Shares [Member]
ADR [Member]
Technical equipments.
Technical Equipments [Member]
Technical Equipment [Member]
Expiration period of stock option plan.
Expiration Period of Stock Option Plan
Stock option expire, years
Adjustments for decrease (increase) in subsidies and tax receivables to reconcile profit (loss) to net cash flows provided by (used in) operating activities.
Adjustments for Decrease (Increase) in Subsidies and Tax Receivables
Decrease (increase) in subsidies and tax receivables
Disclosure of sensitivity analysis on the expected volatility [table text block]
Disclosure of sensitivity analysis on the expected volatility explanatory
Disclosure of sensitivity analysis on the expected volatility
Disclosure of accounting policy for changes in accounting estimates explanatory.
Disclosure of accounting policy for changes in accounting estimates explanatory
Use of judgment, estimates and assumptions
Auditor Name
Decrease In Other Operating Income (Expenses)
Decrease in other operating income (expenses).
Decrease in other operating income (expenses)
The amount of provisions for employee litigation and severance, amounts used during the period.
Provisions for employee litigation and severance amounts used during the period
Employee litigation and severance, Amounts used during the period
Shares receivable on conversion of warrants as a percentage of shares entitlement on conversion on notes receivable.
Shares Receivable On Conversion Of Warrants As A Percentage Of Shares Entitlement On Conversion On Notes Receivable
Shares receivable on conversion of warrants as a percentage of shares entitlement on conversion of notes receivable
Date of grant of share-based payment arrangement
Date
Purchase of property, plant and equipment, classified as investing activities
Acquisition of property, plant and equipment
Purchase of property, plant and equipment
Decrease in non-current restricted cash.
Decrease in Non-Current Restricted Cash
Decrease in non-current restricted cash
Research and development expense
Research and development expenses
Total research and development expenses
Repayments of borrowings, classified as financing activities
Decrease in borrowings
Repayments of borrowings
Disclosure of analysis of single amount of discontinued operations [abstract]
The percentage of an expected dividend used to calculate the fair value of share options granted.
Expected Dividend As Percentage
Expected dividends
Non-current liabilities
Non-current liabilities
Total non-current liabilities
Statement of cash flows [abstract]
European investment bank warrants [member]
European investment bank warrants [member]
European Investment Bank Warrants [Member]
Lease remaining period.
Lease Remaining Period
Lease remaining period
The amount of commercial litigations reversal.
Commercial litigations reversal
Commercial litigation, Reversals
Schedule Of Income Statement Of Discontinued Operations
Schedule Of Income Statement Of Discontinued Operations [Line Items]
Schedule Of Income Statement Of Discontinued Operations [Line Items]
Functional currency percentage.
Functional Currency Percentage
Currency denominated percentage
Maximum number of exclusive license for product candidates.
Maximum Number Of Exclusive License For Product Candidates
Maximum number of exclusive license for product candidates
Non-current restricted cash and cash equivalents
Restricted cash
Initial term for selection of candidate products.
Initial Term For Selection Of Candidate Products
Initial term for selection of candidate products
April Thirteen Two Thousand and Twenty One
April Thirteen Two Thousand and Twenty One [Member]
04/13/2021 [member]
Fair value expected life of derivative less one month
Fair value expected life of derivative less one month.
Expected life of derivative -1 month
Fair value of ordinary shares.
Fair Value Of Ordinary Shares
Fair value of ordinary shares
Borrowings, interest rate
Interest rate
Fixed interest rate
Other provision for charges member.
Other Provision For Charges [Member]
Other provision for charges [Member]
Classes of assets [axis]
Classes of assets [axis]
March Fourth Two Thousand and Twenty One [Member]
March Fourth Two Thousand and Twenty One Member [Member]
03/04/2021 [member]
11/04/2024 [member]
November Four Thousand And Twenty Four [Member]
November four thousand and twenty four.
Net deferred tax assets
Net deferred tax assets
Non-adjusting events after reporting period [domain]
Lease liabilities discontinued operation.
Lease Liabilities Discontinued Operation
Lease liabilities discontinued operation
Subsidies receivables current
Subsidies receivables current.
Total subsidies receivables
Employee litigation and severance.
Employee litigation and severance [member]
Employee Litigation and Severance [Member]
Non-controlling interests
Non-controlling interests
Type of equity instruments granted
Type of equity instruments granted
Class A Preferred Shares
Class A Preferred Shares [Member]
Class A Preferred Shares.
Cash flows from (used in) operating activities [abstract]
Cash flows from operating activities
Fair value
Fair Value SIA Derivative
Fair value SIA derivative.
Fair value
Expected volatility, share options granted
Expected volatility
Expected volatility
Calyxt Atm Program Member
Calyxt ATM Program [Member]
Calyxt ATM Program [Member]
Increase in capital from operating activities
Increase (decrease) in capital from operating activities
Increase (decrease) in capital from operating activities.
Entity Address, Country
Other provision for charges other comprehensive income.
Other Provision For Charges Other Comprehensive Income
Other provision for charges, OCI
Decrease in net defined benefit liability in discount rate.
Decrease In Net Defined Benefit Liability In Discount Rate
Decrease in net defined benefit liability in discount rate
March Thirteen Two Thousand Twenty Five [Member]
March thirteen two thousand twenty five
3/13/2025 [member]
Leasehold improvements [member]
Leasehold Improvements [Member]
The amount of commercial litigations additions.
Commercial Litigations Additions
Commercial litigation, Additions
Decrease /increase in cash, cash equivalents and financial assets
Increase decrease in cash, cash equivalents and financial assets
Increase (decrease) in cash, cash equivalents and financial assets
Level 2 of fair value hierarchy [member]
Level 2 [member]
Disclosure of information about consolidated and non-consolidated structured entities.
Disclosure Of Information About Consolidated And Non-consolidated Structured Entities [Line Items]
Disclosure of Information about Consolidated and Non-consolidated Structured Entities [Line Items]
October eight two thousand eighteen.
October eight two thousand eighteen [member]
10/08/2018 [member]
Earnings per share [text block]
Earnings per share
Details Information About Intangible Assets
Disclosure of detailed information about intangible assets [text block]
Comprehensive income, attributable to non-controlling interests
Total comprehensive income, attributable to non-controlling interests
Attributable to non-controlling interests
Subscription price
Subscription Price Per Share
Subscription price per share.
Executive employees.
Executive Employees [Member]
Key management personnel non-cash stock-based compensation expense recognized.
Key management personnel non-cash stock-based compensation expense recognized
Key management personnel non-cash stock-based compensation expense recognized
Auditor Location
Buildings and other outside improvements.
Buildings And Other Outside Improvements [member]
Buildings and Other Outside Improvements [Member]
Provisions For Employee Litigation and Severance
Provisions for employee litigation and severance.
Employee litigation and severance, Ending balance
Employee litigation and severance
Employee litigation and severance, Beginning balance
December Nine Two Thousand Twenty Five [Member]
December nine two thousand twenty five.
12/9/2025 [member]
Other non-current assets
Other non-current assets
Other non-current assets
Decrease in Reclassification current financial assets.
Reclassification In Current Financial Assets
Decrease in reclassification current financial assets
Increase (Decrease) in Fair Value of Warrants
Increase (decrease) in fair value of warrants.
Change in fair value of warrants
Increase in net defined benefit liability in salary increase rate.
Increase In Net Defined Benefit Liability In Salary Increase Rate
Increase of net defined benefit liability
Financial liabilities excluding trades payable and other current liabilities.
Financial liabilities excluding trades payable and other current liabilities
Financial liabilities
B P I Agreement [member]
B P I Agreement.
BPI Agreement [Member]
Addition for non current provision.
Addition For Non Current Provision
Non current provisions additions
Line items represent concepts included in a table. These concepts are used to disclose the amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity.
Expense by Nature [Line Items]
Expense by nature [line Items]
Collaboration agreement.
Collaboration Agreement [axis]
Major components of tax expense (income) [abstract]
Deferred tax assets
Deferred tax assets
Deferred tax assets
Disclosure of subsidiaries [line items]
Proceeds from sales of investments other than investments accounted for using equity method
Sale of current financial assets
Categories of financial liabilities [domain]
Disclosure of revenue [line items]
Disclosure of revenue [line items]
Disclosure of revenue [line items]
Types of warrants [Domain]
Types of warrants [Domain]
Disclosure of transactions between related parties [table]
The amount represents the research tax credit income for the period. The research tax credit is a French tax credit calculated based on our claimed amount of eligible research and development expenses in France. It can be offset against French corporate income tax due and the portion in excess (if any) may be refunded at the end of a three fiscal-year period.
Research Tax Credit Amount
Research tax credit subsidy
Research Tax Credit
Furniture fixtures and office equipment.
Furniture Fixtures and Office Equipment [member]
Office Furniture [member]
Entity Interactive Data Current
Fair value per options.
Fair Value Per Options
Fair value per options (in euros per share)
Fair value per options
Bank deposits, not classified as cash equivalents.
Bank Deposits Not Classified As Cash Equivalents
Bank deposits
Additional Manufacturing Activities to Support R&D Pipeline [Member]
Additional Manufacturing Activities to Support R&D Pipeline.
Increase decrease in accruals for personnel related expense.
Increase Decrease In Accruals For Personnel Related Expense
Decrease in accruals for personnel related expenses
Increase (decrease) in foreign exchange gains.
Increase (decrease) in foreign exchange gains
The entire disclosure in details of financial liabilities.
Disclosure of detailed financial liabilities explanatory
Financial liabilities
Financial liabilities at fair value through profit or loss
Total financial liabilities at fair value through profit or loss
Fair value other current liabilities
Disclosure of impairment loss and reversal of impairment loss [line items]
Depreciation & Impairment Expense
Depreciation & impairment expense.
Depreciation & impairment expense
Changes in deferred tax liability (asset) [abstract]
Measurement [axis]
Other current liabilities.
Other current liabilities [abstract]
Proceeds Received In Collaboration Agreement
Proceeds received in collaboration agreement.
Proceeds reallocated to the JRCA
Disclosure of Activities of Company Explanatory
Disclosure of Activities of Company Explanatory
The Company
Financial assets
Financial assets
Financial assets at beginning of period
Financial assets at end of period
Total financial assets
Disclosure of quantitative information about right-of-use assets [text block]
Right-of-use assets
Other comprehensive income (loss) from discontinued operations
Other comprehensive income (loss) from discontinued operations
Other comprehensive income (loss) from discontinued operations.
Fair value of the retained investment
Discontinued Operations Fair Value Of Retained Investment
Discontinued operations, fair value of retained investment.
Net assets, liabilities and equity derecognized
Net Assets, Liabilities And Equity Derecognized
Net assets, liabilities and equity derecognized.
Disclosure of classes of share capital [abstract]
Issued capital [member]
Share Capital Issued Capital [member]
Share capital [member]
Non recognition of deferred tax assets related to tax losses and temporary differences
Tax Effect Of Non Recognition Of Deferred Tax Assets Related To Tax Losses And Temporary Differences
Tax effect of non recognition of deferred tax assets related to tax losses and temporary differences.
Put Options May Twenty Six And Twenty Twenty Six [Member]
Put options may twenty six and twenty twenty six.
Put options
Increase (decrease) through other changes, equity
Other movements
Later than one year and not later than five years [member]
One to Five Years [member]
Number Of Shares To Be Issued
Number of shares to be issued.
Number of shares issued
Number of shares to be issued
State Guaranteed Loan.
State Guaranteed Loan [Member]
State Guaranteed Loan [Member]
Consolidated entities and non-controlling interests
Description Of Accounting Policy For Consolidated Entities And Non controlling Interests Explanatory
Description of accounting policy for consolidated entities and noncontrolling interests explanatory.
Weighted average remaining contractual life of outstanding share options
Remaining Average Useful Life
Later than three years and not later than five years [member]
3-5 years [member]
Local Phone Number
Other current liabilities
Other current liabilities
Total other current liabilities
Agreement two.
Agreement Two [Domain]
Subscription Price Per Share Options Granted
Subscription price
Subscription price
Disclosure of offsetting of financial liabilities [table]
Disclosure of offsetting of financial liabilities [table]
The increase (decrease) in liabilities arising from financing activities resulting from financing cash flows, excluding interest payments.
Increase (Decrease) Through Financing Cash Flows (Excluding Interest Payments), Liabilities Arising from Financing Activities
Debt repayments financial liabilities and lease debts
Auditor Opinion [Text Block]
Auditor Opinion
Warrants Valuation.
Warrants Valuation [Abstract]
Percentage of decrease in discount rate.
Percentage Of Decrease In Discount Rate
Percentage of decrease in discount rate
Other comprehensive income that will be reclassified to profit or loss net of tax from continuing operations.
Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax From Continuing Operations
Other comprehensive income (loss) that will be reclassified subsequently to income or loss from continuing operations
The increase in contract liability balances resulting from consideration received from customers.
Increase Due to Consideration Received from Customers, Contract Liabilities
Additional consideration from customers
Personnel expenses
Compensation expense
Total employee benefits expense
Share-based compensation expense
Employee benefits expense
Personnel expenses
The increase in liabilities arising from financing activities resulting from the non-cash capitalization of interest expense.
Increase Through Capitalization of Interest Expense (Non-Cash), Liabilities Arising from Financing Activities
Interest expense financial liabilities and lease debts
Contractual life options.
Contractual Life Options
Contractual life of options
Lease potential obligations.
Lease Potential Obligations
Lease potential commitment
Schedule of Share Capital Information
Disclosure of Detailed Information of Share Capital Explanatory [text block]
Disclosure of Detailed Information of Share Capital Explanatory.
Adjustments to reconcile profit (loss) [abstract]
Adjustment to reconcile net income (loss) to cash provided by (used in) operating activities
Expected amount of discounting adjustment.
Expected Amount of Discounting Adjustment
Expected amount of discounting adjustment
Loans received
Liability related to the EIB loan
Accrued and unpaid interest accrued.
Accrued And Unpaid Interest Accrued [Member]
Disclosure Of Number And Weighted Average Exercise Prices Of Share Options AND Awards [Abstract]
Disclosure Of Number And Weighted Average Exercise Prices Of Share Options AND Awards [Abstract]
Deferred tax assets
Deferred Tax Asset Gross
Deferred tax asset gross.
Levels of fair value hierarchy [domain]
November four two thousand and twenty four [Member]
November four two thousand and twenty four.
Increase in number of preferred shares issued.
Increase in number of preferred shares issued
Capital increase, Shares
Entity Emerging Growth Company
Accounting category fair value through profit and loss
Financial assets at fair value through profit or loss
Total financial assets at fair value through profit or loss
Income Tax Authorities [Domain]
Income tax authorities.
The portion of the research tax credit receivable which is expected to be refunded within twelve months after the reporting period.
Reserach tax credit receivable current
Research tax credit